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Extracellular matrix (ECM) scaffolds offer an alternative treatment to repair damaged cardiac 
tissue by promoting the formation of functional host tissue. While promising, the methods used 
to manufacture ECM scaffold materials vary widely with different source tissues, detergents, 
methods of application, and duration. This variability results in differences in the final ECM 
composition and structure that can lead to inconsistent clinical outcomes. Minimal information 
exists regarding the physical and biological effects of different detergent treatments used for 
decellularization upon the resultant ECM scaffold.  
Cardiac tissue includes both the ECM structure and composition, each of which has 
reciprocal effects upon cell phenotype and gene expression. This cell-ECM interaction was 
evaluated by cell deformation and biosynthetic activity and was found to be dependent on 
localized mechanical coupling to the fiber network. Differences were noted by anatomic location 
and tissue layer. A therapeutic strategy to replace damaged cardiac tissue with site-specific 
cardiac derived ECM scaffolds may thus be advantageous. However, different detergent 
treatments used to decellularize may negatively impact this microstructural complexity and the 
associated downstream beneficial effects upon tissue remodeling. 
Two clinically relevant source tissues, urinary bladder and heart, were treated with four 
detergents commonly used for tissue decellularization: a non-ionic detergent (Triton™ X-100), a 
zwitterionic detergent (CHAPS), and two ionic detergents (sodium deoxycholate and SDS). For 
bladder tissue, detergents were applied through immersion and mechanical agitation, and for 
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myocardium, detergents were applied through whole organ retrograde perfusion. The 
composition, structure, mechanics, and in-vitro cytocompatibility of the resultant ECM materials 
were characterized.  
Results show that Triton™ X-100 adequately decellularized bladder tissue but not 
myocardium during whole organ perfusion. Sodium deoxycholate and SDS were found to be 
highly effective for decellularization. CHAPS and SDS resulted in a loss of ECM constituents 
such as GAGs and denatured the collagen fiber network. Failure strength was unaffected by 
detergent choice. These findings for CHAPS and SDS correlated with a poor in-vitro 
cytocompatibility. Triton™ X-100 and sodium deoxycholate retained composition, structure, and 
in-vitro cytocompatibility. This information may assist in the development of rational strategies 
for effective decellularization of tissues while maintaining ECM structure-function properties. 
 vi 
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1.0  INTRODUCTION 
1.1 HEART FAILURE AND TREATMENT STANDARD 
The function of the heart is to pump blood through a network of arteries and veins called the 
cardiovascular system for nutrient transport, oxygen transport, and metabolic waste removal. 
Cardiovascular disease is a broad term to describe the malfunction of both the heart and 
cardiovascular system. This term encompasses the narrowing of blood vessels, coronary artery 
disease, heart rhythm problems, heart infections, and congenital heart defects. Cardiovascular 
disease accounts for more than one in three deaths in the United States and had an estimated cost 
of $300 billion in 2009 alone (1). The first line of treatment requires lifestyle changes such as 
diet and exercise coupled with medication to lower blood pressure, prevent coagulation, and 
lower cholesterol. The next line of treatment after severe angina is either coronary angioplasty or 
bypass, a surgical procedure to open a narrow blocked coronary or reroute blood supply around 
the damaged site using a healthy artery from the lower leg. If heart failure is reached whereby the 
heart is unable to pump enough blood to meet the body’s demands, then treatment options are 
limited.  
Over 3 million Americans over the age of twenty have heart failure with an estimated 
cost of $32 billion for 2013 (1), and of these patients 200,000 have severe class IV heart failure 
(2). Treatment options are limited to either pharmacologic therapy such as the use of diuretics to 
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treat volume overload for symptom relief, mechanical circulatory support, or heart transplant (3). 
While heart transplant represents the gold standard of treatment, in 2011 less than 2,500 heart 
transplants were performed in the United States due to donor shortage. To be eligible for a heart 
transplant, the patient needs to be younger than 65 years of age without significant comorbidity 
(1, 2). For those patients unable to receive a heart transplant, a ventricular assist device (VAD), a 
form of mechanical circulatory support, is the only other option. Compared to pharmacologic 
therapy alone, a VAD is superior offering a reduction in mortality rate of 27% at one year (4).  
While VADs are a promising technology, they are not without limitations. VADs require 
anticoagulation therapy to prevent thromboembolism due to the artificial surface of the VAD. 
With an increased risk of thromboembolism there is an associated increased risk of stroke and 
transient ischemic attacks. The necessity for anticoagulation therapy along with a lack of 
pulsatile flow also presents a risk of bleeding especially in the gastrointestinal space if not well 
managed (5, 6). VAD-related infections are a prevalent complication and contribute to 
significant financial burden due to increased need for hospitalization and surgical intervention. 
VAD related infections are common along the driveline whereby a percutaneous lead connects 
the internal LVAD motor to an external power supply, although there may also be pump pocket 
infections, and LVAD associated endocarditis. Patients with VADs have limited mobility due to 
an accompanied device controller that requires battery power.  
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While this promising technology is improving with time there is a definitive limitation in 
that a mechanical circulatory support system does not grow or remodel with the patient, which is 
especially critical for pediatric patients who will require increasing cardiac output with age. The 
recent advances in cardiovascular tissue engineering offer a potential platform whereby novel 
medical devices may grow and remodel with the patient. Such advances are critical to improve 
the 5-year survival rate of heart failure patients which is only 50% (1). 
1.2 CARDIOVASCULAR TISSUE ENGINEERING 
Tissue engineering is defined as an “interdisciplinary field that applies the principles of 
engineering and life science towards the development of biological substitutes that restore, 
maintain, or improve function” (7). At least 70 companies have developed or are developing 
tissue engineered products (8). Tissue engineering can further be subdivided into three 
categories: Cell-based products, cell-free supports, and whole tissues that combine technologies 
from both cell-based products and cell-free supports (8). Cell-free supports are commonly 
referred to as biomaterials and may be classified as either synthetic or biologic.  
1.2.1 Synthetic Scaffolds  
Synthetic technologies utilize either non-absorbable polymers such as polypropylene or 
biodegradable polymers such as poly(ether ester urethane)urea (PEUU) elastomers (9). The 
objective of manufacturing biomaterials with synthetic technologies is to replicate the structure 
of the native tissue or organ with the assembly of biomimetic fibers. Methods of manufacturing 
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include such techniques as nano-patterned surfaces, microfabrication, electrospinning, and 
assembled hydrogels (8). These methods of manufacturing create reproducible sheet-structures 
with controllable mechanical properties. A challenge with these techniques is the limited ability 
to create three-dimensional porous scaffolds with nano-topographies. Further, while non-
absorbable polypropylene synthetic meshes quickly incorporate into the adjacent tissue, they 
elicit a chronic pro-inflammatory response characterized by the formation of dense fibrotic tissue 
within and around the mesh (10). Meshes with absorbable filaments are reported to have an 
augmented inflammatory reaction initially (11) with a subsequent decrease in the inflammatory 
reaction (12, 13). This formation of fibrotic tissue leads to a mechanical mismatch between the 
mesh and surrounding host tissue that is associated with pain and discomfort for the recipient 
(14, 15).  
1.2.2 Biologic Scaffolds 
Tissue engineering devices that are derived from biologic platforms instead of synthetic 
platforms provide both structural support and functional cues. Biologic scaffolds composed of 
mammalian extracellular matrix (ECM) have been successfully used in both pre-clinical and 
clinical applications for surgical reconstruction of musculotendinous, dermal, cardiovascular, 
gastrointestinal, and lower urinary tract tissue (16-28). The ECM represents the secreted products 
of resident cells and includes structural proteins such as collagen and elastin, adhesion proteins 
such as fibronectin and laminin, proteoglycans, growth factors, and cytokines (29, 30).  
Allotransplantation of an organ from one human to another requires immunosuppression 
therapy. Xenotransplantation is not possible in part due to porcine cell expression of the α-gal 
epitope and other cell associated epitopes (31). Conversely, ECM is actually highly conserved 
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amongst many species (32-34) mitigating adverse components of the host immune response (35). 
These biologic cues in ECM have been shown to influence cell migration, proliferation, and 
differentiation (36-42). ECM scaffolds promote a constructive remodeling response by 
modulation of the immune response (43, 44), mechanotransduction at the site of injury (45, 46), 
rapid degradation and release of bioactive peptides (47-49), and site directed recruitment of 
progenitor cells (43, 44, 50, 51). A constructive remodeling response modulates the three phases 
of wound healing (inflammation, proliferation, and maturation) to form site appropriate new 
tissue as opposed to scarring. While scarring is characterized by the deposition of a dense 
collagenous ECM that lacks blood supply and nerves independent of anatomic location, a 
constructive remodeling response results in healthy viable tissue that more closely matches the 
surrounding area (Table 1). 
Table 1: Comparison of a constructive remodeling response to scarring. 
 Vascularized Innervated Tissue Composition Structure Mechanics 
Constructive 
Remodeling Yes Yes 
Site specific (connective, 
muscle, epithelial) 
Organized fiber 
network 
Similar to 
surrounding tissue 
Scarring 
No No Dense collagenous matrix 
Randomly 
oriented collagen 
Stiffer than 
surrounding tissue 
1.2.3 Site-Specific ECM Scaffolds and Organs 
ECM scaffolds are derived from multiple anatomic sites including intestine (52, 53), urinary 
bladder (17), skin (54), heart valves (55, 56), brain, spinal cord (57), liver (58), and heart (59, 
60). Because the ECM is the product of the resident cell populations, it is logical that the specific 
composition will vary depending on the source tissue, and that the ECM product will be ideally 
suited for application to the tissue from which it is harvested (61). For example, ECM harvested 
from the liver compared to collagen gel cultures promoted significant improvement in albumin 
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synthesis and urea production for seeded hepatocytes (62), and a coculture of sinusoidal 
endothelial cells and hepatocytes maintained the greatest degree of differentiation on liver ECM 
compared to either UBM or SIS (63).  
Anatomically homologous ECM scaffolds have demonstrated functional improvement in 
preclinical and clinical applications for the liver (62-64), heart (65, 66), lungs (67), trachea (68), 
nerve (69), adipose (70), and mammary gland [51]. Recent studies have further demonstrated the 
successful creation of three-dimensional ECM scaffolds prepared by whole organ 
decellularization with organs such as the heart (65, 71, 72), liver (64), lungs (67, 73), and kidney 
(74). Logically, these ECM scaffolds possess the ideal three-dimensional architecture for all 
components of the organ including vascular, lymphatic, and nerve structures.  
Thus, tissue engineered devices that are derived from biologic platforms compared to 
synthetic platforms offer the potential to successfully incorporate into the surrounding tissue for 
site specific function. While synthetic platforms offer reproducibility and control over the 
structure and mechanics, biologic platforms offer the ability to retain a complex heterogeneous 
three-dimensional structure with constituents that promote a site specific constructive remodeling 
response.  
1.3 ECM SCAFFOLDS FOR CARDIAC REPAIR  
1.3.1 Myocardial Infarction and Negative Ventricular Remodeling 
While heart transplants and ventricular assist devices are promising technologies for patients 
with end stage heart failures, they clearly have limitations. After a myocardial infarction new 
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therapy is necessary to prevent progressive negative ventricular remodeling that may lead to end 
stage heart failure. Progressive negative ventricular remodeling commences after a myocardial 
infarction in a multiple step process (75-78): (1) Degradation of associated ECM and an acute 
inflammatory response, (2) formation of dense collagenous scar due to limited regenerative 
capacity of myocardium, (3) hypertrophy of myocardium to compensate decrease pumping 
capability of infarct area, and (4) ventricle dilation with continued infarct wall thinning to 
maintain cardiac output by increasing stroke volume. After a myocardial infarction, the 
magnitude of this ventricular dilation is a predictor of poor long term outcome (79). 
Pharmacologic therapies such as angiotensin converting enzyme inhibitors and β-blockers are 
used to reduce ventricular remodeling and have proven beneficial in treatment of heart failure 
(80). 
1.3.2 ECM Scaffold Patches for Cardiac Repair 
Cardiovascular tissue engineering approaches attempt to attenuate this post-infarction ventricular 
dilation by surgical restoration with a ventricular patch or restraint device. The majority of 
cardiac patches and restraint devices have been designed from non-biodegradable synthetic 
materials such as Dacron, polyester, and nitinol with low elasticity. These devices are 
characterized by a chronic foreign-body response and no constructive remodeling nor contractile 
restoration (81-84). Highly elastic and biodegradable polymers such as poly(ester urethane)urea 
elastomers (PEUUs) have recently demonstrated promise in animal models with the promotion 
of cardiomyocytes and improved LV function (85, 86). While promising, these biodegradable 
polymers do not contain bioactive molecules to promote constructive remodeling.  
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Compared to synthetic polymers, ECM scaffolds promote both structural support and 
functional cues for cardiac repair. An anatomically site specific cardiac ECM scaffold (71) was 
recently used in a rodent model of a full thickness right ventricle outflow tract repair (RVOT) 
compared to an inert Dacron patch up to 4 months (87). The Dacron patch was encapsulated with 
a fibrous capsule with minimal cellular infiltration, while the c-ECM patch remodeled into a 
dense connective tissue with scattered islands of striated cardiomyocytes with superior 
echocardiography results.  
While this anatomically site specific cardiac ECM scaffold is promising, non-site specific 
ECM scaffolds have also demonstrated efficacy. Specifically, a 4-layer multi-laminate urinary 
bladder matrix (UBM) ECM was compared to expanded polytetrafluoroethlyne (ePTFE) in a full 
thickness LV wall patch replacement in a porcine animal model up to 3 months (88). At 3 
months, histology and immunohistochemistry indicated that UBM was bioresorbed with a 
vascularized tissue with numerous α-SMA positive myofibroblasts present and isolated regions 
of striated cardiomyocytes, while ePTFE had a fibrotic-body response with necrosis and 
calcification. Flow cytometry indicated that UBM had a similar composition of cells to normal 
myocardium as opposed to ePTFE which had limited cardiomyocyte markers. In a separate study 
UBM was applied to an experimentally produced defect in the right ventricular free wall in a 
canine model and compared to a Dacron patch for up to 8 weeks (89). The UBM-treated defect 
area showed greater systolic contraction compared to the Dacron treated area. Histology showed 
fibrotic reaction surrounding Dacron with no myocardial regeneration, but UBM showed 
cardiomyocytes staining positive for α-SMA and connexin 43.  
Recently, the effectiveness of organ specific c-ECM was directly compared to a UBM in 
a rodent RVOT repair (90). Both ECM scaffolds had no signs of fibrotic encapsulation and were 
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able to preserve cardiac performance, support cell infiltration, and support an endothelial lining 
along the endocardial surface. Surprisingly, the UBM patch rapidly degraded and remodeled 
with the formation of cardiomyocytes by 16 weeks compared to the c-ECM patch with little 
evidence of remodeling. While the non-site specific UBM resulted in the formation of a higher 
level of myocardial tissue compared to the site specific c-ECM in this study, both are being 
investigated for their promise in the treatment of negative ventricular remodeling after 
myocardial infarction. Currently only one company, CorMatrix, is utilizing ECM for cardiac 
related repairs of pericardium, cardiac tissue, and carotid repair using a non-site specific ECM 
scaffold called small intestinal submucosa (SIS). 
1.3.3 Minimally Invasive Injectable ECM Gels for Cardiac Repair 
Another approach to the treatment of myocardial infarction is to inject a bioactive gel into the 
damaged region. A gel form of a cardiac ECM scaffold was prepared (60) by enzymatic 
solubilization with pepsin into a liquid and then induction of self-assembly into a gel when 
brought to physiologic conditions of 37 °C and pH of 7.4 (91). This gel form of ECM was 
injected directly into the LV free wall of a rodent. Endothelial cells and smooth muscle were 
found to migrate into the site of injection, and at 11 days post-injection there was an increase in 
arteriole formation (60). Recently, infarcted pigs were treated with cardiac ECM gels through a 
percutaneous transendocardial injection two weeks after MI and evaluated at 3 months. 
Echocardiography indicated improvement in cardiac function and ventricular volumes, and there 
was a significant increase in cardiac muscle at the region of injection (66). This cardiac ECM gel 
is licensed to a company called Ventrix and is planning to begin human clinical trials in quarter 
four of 2013.  
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1.3.4 Whole Organ ECM Scaffold Engineering 
While cardiac patch and minimally invasive injectable gel technologies are promising, they are 
not feasible solutions to severe class IV heart failure where a transplant is required. Whole organ 
tissue engineering, however, may one day alleviate the supply-demand mismatch of available 
transplants. It has been demonstrated that an entire porcine heart can be decellularized by 
coronary perfusion. This three-dimensional ECM scaffold was found to retain collagen, elastin, 
glycosaminoglycans, and mechanical integrity providing a microenvironment to support site-
appropriate cell differentiation and spatial organization. A group used this technique to create a 
tissue engineered heart by reseeding a decellularized rat heart with neonatal cardiomyocytes, 
fibroblast, endothelial cells, and smooth muscle cells, culturing in an incubator for ten days, and 
applying an external electrical stimulus to generate an organ level contractile force. While this 
force was only 2% of adult rat heart or 25% of a 16-week fetal human heart it demonstrated that 
a decellularized heart may be a potential platform for a xenogeneic tissue engineered heart 
replacement (71). While whole organ decellularization to produce a tissue engineered heart will 
take further time to develop, ECM scaffolds and gel for cardiac repair of a myocardial infarcted 
region provide a promising solution in the near future.  
1.4 MECHANICAL LOADING AT THE SITE OF ECM IMPLANTATION 
A mismatch in mechanical compliance at the site of cardiac repair can lead to a poor outcome 
(88, 89). Whereas a Dacron patch is stiff, a tissue derived ECM scaffold may match the 
mechanical compliance of cardiac tissue. An ECM scaffold as a cardiac patch or as a whole 
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organ replacement may match this mechanical compliance because it is derived from native 
tissue, thus containing an ideal three-dimensional composition and structure. The mechanical 
response of an ECM scaffold is largely dictated by the collagen fiber network.  
1.4.1 Composition and Structure of ECM Fiber Networks 
Depending on the source tissue the collagen fiber network can be starkly different. Collagen 
fibers themselves are diverse in composition. Collagen accounts for a third of all body protein, 
and twenty-eight different types of collagen have been identified in vertebrates (92). 80-90% of 
collagen consists of fibrillar collagen sub-units composed of type I, II, III and V collagen. These 
collagen sub-units are synthesized from cells such as fibroblast and osteoblast. Each fibrous 
collagen sub-unit consists of three α chain left-handed coiled subunits each composed of 1050 
amino acids that form a right handed super-helix (93). The collagen sub-units differ due to the 
amino-acid sequence, the segments that interrupt the triple helix, and the higher order three-
dimensional structures that are subsequently formed. Collagen type I, for example, is 300 nm 
long and 1.5 nm in diameter. These fibrous collagen molecules are capable of packing together 
to form fibrils of a diameter 40-300 nm with a staggered arrangement. The strength of fibrils is 
imparted by the development of intermolecular cross-links. Fibrils may pack together to form 
fibers with a diameter of 1-10 µm, which may then form into primary or secondary bundles 
called fascicles (92).  
These collagen fibers form into networks that are distinct for each anatomic location and 
only contain certain types of collagen. Both collagen types I and III are found in tendons, 
ligaments, muscle, blood vessels, and scar. Type I collagen is also found in bone. For dermis the 
fiber network forms a pattern of interlacing bundles, for intervertebral discs they exist in broad 
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adjacent sheets with different directions, in tendons they exist in bundles (92), and in heart they 
exist in sheets with altering directions as the thickness of the myocardium is traversed (94). Type 
II collagen is found in cartilage and its fibrils are smaller in diameter than type I, oriented 
randomly in a proteoglycan ECM imparting compressibility to absorb joint shock. Type IV and 
V collagen are nonfibrillar and generally found in basal laminae or basement membranes and 
synthesized by epithelial cells. Elastin is another non-collagenous fibrous protein consisting of 
polypeptide chains covalently cross-linked. The individual protein molecules in elastin are able 
to uncoil reversibly whenever force is applied (92).  
1.4.2 ECM Structure-Mechanics Relationship 
These heterogeneous fiber networks are mechanically complex (95) and are subject to large 
deformation that exhibit a highly non-linear stress–strain relationship characterized by a 
compliant response or toe region at low strains and a stiff response at large strains. ECM 
scaffolds also exhibit viscoelasticity, and complex axial coupling. Much of this behavior is due 
to changes in the fiber network’s internal structure with strain, which involves both straightening 
of crimped collagen fibers and rotation of these fibers toward the stretch axis. The fibers within 
the network may have a degree of alignment depending on the source tissue that correlates at the 
macro scale with a degree of mechanical anisotropy.  
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1.4.3 ECM and Mechanotransduction 
For cardiac tissue, the fiber networks orient the myocytes, mechanically couple them to each 
other and to neighboring capillaries and nerves, and provide elastic support during ventricular 
filling. Acute disruption of this fiber network decreases myocardial systolic performance without 
even a change to myocyte contractility because the network maintains continuity between 
myocytes (96). Myocytes are bound to the ECM network through cell surface ECM receptors 
known as integrins. Integrins are dimeric transmembrane proteins composed of an α and β 
subunit that bind ECM proteins in the extracellular space and cytoplasmic actin-linker proteins 
inside the cell, thereby mechanically coupling the ECM to the actin cytoskeleton. The binding of 
a cell integrin to an ECM protein results in a conformational change whereby receptors cluster 
together to form a focal adhesion complex. This focal adhesion complex contains a cluster of 
integrins, associated actin-linker proteins, and multiple signal transduction molecules.  
Focal adhesions are critical to mechanotransduction, the process by which cells convert 
mechanical signals into biochemical responses. Global forces are transmitted through the ECM 
and focused on cell surface integrin receptors. This global force causes a localized force 
dependent change in cell shape and the confirmation of the focal adhesion. This confirmation 
change alters the focal adhesion’s biochemical activity resulting in signal transduction and 
associated stress-dependent remodeling. An experiment that disrupted intracellular force 
transmission through interfering with expression of focal adhesion protein vinculin actually 
impaired myocyte shape stability and disrupted normal myofibril architecture (97). It also has 
been demonstrated that a cardiac specific signaling molecule melusin is activated by binding β1 
integrin to mediate the cardiomyocyte response to pressure overload hypertrophy to prevent 
cardiac failure (98). Ion channel function also is influenced by the relationship between local 
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integrins and mechanical forces through the ECM. To summarize, external mechanical loads 
exerted on cardiomyocytes can induce alterations in gene expression, muscle mass, and 
phenotype. These effects are mediated by force dependent signal transduction through the ECM. 
Thus, mechanical forces conveyed by the ECM are critical in the control of heart form and 
function (99).  
1.5 THE MANUFACTURING OF AN ECM SCAFFOLD 
The objective of decellularization of a source tissue is to remove the cellular components to 
prevent host rejection while minimizing alteration to the remaining ECM composition and 
structure. Decellularization of tissues and organs to create ECM scaffolds is a complex multiple 
step process. The decellularization process will vary depending on factors such as a tissue’s 
cellularity, density, lipid concentration and thickness (100). To acquire a better understanding of 
the decellularization process, a description of the potential methods in a protocol are provided 
below. 
1.5.1 Chemical Decellularization Agents 
Decellularization agents may be classified into chemical and biologic agents. Chemical agents 
may be further broken down into either acids and bases, hypotonic and hypertonic solutions, 
detergents, alcohols, or other solvents. Acids and bases catalyze hydrolytic degradation of 
biomolecules. Peracetic acid is a common disinfection agent that also acts as a decellularization 
agent by removing residual DNA. Hypotonic and hypertonic saline solutions cause cell lysis by 
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alternating between osmotic affects that cause cell swelling and shrinking. Hypertonic saline 
solutions also dissociate DNA from proteins (101). Detergents solubilize cell membranes and 
dissociate DNA from proteins. Detergents are effective at removing cellular material from 
tissues but are known to disrupt and dissociate proteins. Alcohols aid in both cell lysis and lipid 
removal. Other solvents such as acetone also may aid in lipid removal, but similar to alcohol, 
they may cause tissue fixation and damage ECM structure. 
1.5.2 Biologic Decellularization Agents 
Biologic agents may be separated into either enzymes or non-enzymes. Enzymes such as 
nucleases, trypsin, collagenase, and lipase can provide high specificity for removal of cell 
residues or undesirable ECM constituents, but they are typically insufficient for complete 
cellular removal if used alone and may be cost ineffective compared to other decellularization 
agents depending on the volume of solution required. Non-enzymes such as chelating agents 
(ethylenediaminetetraacetic acid or EDTA) aid in cell dissociation from ECM proteins by 
binding to metal ions but are also insufficient when used alone and are most effective when 
combined with enzymes such as trypsin. Antibiotics and antimycotics such as penicillin, 
streptomycin, amphotericin B, and sodium azide may be used to inhibit microbial contamination 
during decellularization but also present a regulatory hurdle for clinical approval.  
1.5.3 Techniques to Apply Decellularization Agents 
The techniques to apply decellularization agents will depend on the tissue’s thickness and 
density. For example, while thin tissue such as pericardium may be successfully decellularized 
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by immersion in a detergent solution with mechanical agitation alone, a very thick and dense 
tissue such as myocardium will not sufficiently decellularize by diffusion alone if left intact. For 
some tissues, prior to application of decellularization agents, undesirable layers of the tissue may 
be mechanically removed. For example, for the preparation of UBM the mucosal and 
submucosal of the bladder are first mechanically separated to isolate the basement membrane 
complex (BMC) and lamina propria, which is subsequently mechanically shaken in peracetic 
acid for 2 hours to both decellularize and disinfect (102). The thickness of the BMC and lamina 
propria is small enough for diffusion of the detergent from the surface to traverse the layers. 
However, the heart is too thick to achieve decellularization by detergent immersion and 
mechanical shaking.  
The heart must either be cut into smaller pieces and mechanically agitated for prolonged 
periods of days (103), or decellularized as a whole organ through retrograde perfusion with 
detergent (65, 71, 72). Retrograde perfusion of the heart largely preserves the three-dimensional 
architecture of the organ compared to cutting it into smaller pieces. Retrograde perfusion 
accesses the vascular network within the myocardium to minimize the diffusion distance for 
detergents to the cells. To achieve retrograde perfusion in the heart the ascending aorta is 
cannulated, and a peristaltic pump moves fluid in the direction of the aortic valves which 
subsequently coapt under the retrograde pressure. This fluid is then forced to flow through the 
coronary arteries at the sinuses of the aortic valve. Perfusion through this coronary vasculature is 
an efficient method to both deliver decellularization agents to cells and to remove cellular 
material from the tissue.  
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1.5.4 Differences in Decellularization Protocols 
For each tissue and organ there are multiple reported protocols for decellularization that differ in 
the number, order, type, concentration, and application time of decellularization agents. For 
example, one protocol commonly used for decellularization of hearts over 136 hours (65) utilizes 
retrograde perfusion with (1) heparinized PBS with adenosine to remove blood product, (2) an 
ionic detergent called SDS to remove cellular content, (3) a non-ionic detergent called Triton™ 
X-100 to both remove cellular content and rinse out SDS, and (4) a rinse with an antibiotic PBS 
solution to remove detergent residues. In this protocol each step is followed by rinsing with 
deionized water to remove detergent residues. 
Another protocol for heart decellularization (71) used (1) the enzyme trypsin with EDTA 
and sodium azide to detach cells from the ECM, (2) Triton™ X-100 with EDTA and sodium 
azide, (3) an ionic detergent called sodium deoxycholate to remove cellular content, and (4) 
peracetic acid to both disinfect and decellularize. Between each step of this protocol there were 
rinses with type I water and 2x PBS to lyse the cells through osmotic effects. The process of 
decellularization of porcine heart through this protocol is reduced to less than 15 h. Thus, even 
for whole organ decellularization of a heart there are different protocols with many differences in 
the types of detergents used, their sequence, and duration of application.   
1.5.5 Decellularization Protocols, ECM Composition, and Host Response 
Preservation of the complex composition and three-dimensional ultrastructure of the ECM 
during manufacturing of these devices is highly desirable, but it is recognized that all methods of 
tissue decellularization result in some degree of disruption of the architecture with potential loss 
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of surface structure and composition (100). For example, when the processing methods do not 
effectively decellularize the source tissue or when chemicals are involved that create non-
degradable molecular cross-links, the in-vivo soft tissue remodeling response is characterized by 
chronic inflammation, fibrotic encapsulation, and scar tissue formation (44, 104, 105). When the 
processing methods do effectively decellularize the tissue and chemicals that create non-
degradable molecular cross-links are avoided, then the in-vivo remodeling response is 
constructive with the formation of site-specific functional tissue.  
An examination of distinct processing steps used to achieve decellularization for dermis 
(106), cornea (107, 108), lung (109), heart valves (110), and pericardial tissue (72, 103, 111-113) 
found that the type and sequence of detergents used can cause marked changes in the 
composition, mechanical strength, and/or cytocompatibility of the resultant ECM scaffold. For 
example, for the decellularization of dermis it was found that liming decreased growth factor, 
GAG content, mechanical strength, and the ability of ECM to support in-vitro cell growth. A 
combination of trypsin, SDS, and Triton™ X-100 decreased growth factor content and in-vitro 
cell growth compared to just trypsin and Triton™ X-100 (106). Comparison of multiple step 
protocols for whole heart decellularization found distinct differences in DNA content, GAG 
content, and ECM constituents such as collagen IV, elastin, and laminin (113).  
1.5.6 Detergents in Decellularization Protocols 
Detergents are commonly used to decellularize tissues. The usage of different types of detergents 
in multiple step protocols may contribute to the distinct differences in ECM scaffold 
composition. To understand why detergents may effect ECM scaffold composition an 
understanding of their mechanism of action is necessary. Detergents facilitate cellular lysis and 
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solubilize the released hydrophobic proteins (114, 115). Cellular membranes are composed of 
phospholipids that are amphipathic containing a hydrophobic non-polar hydrocarbon tail 
connected to a hydrophilic polar head group. This structure aggregates to form a lipid bilayer in 
which hydrophilic polar head groups are oriented towards the aqueous environment forming 
hydrogen bonds with water molecules, while the hydrophobic tails are oriented inwards between 
the hydrophilic head groups. Integral membrane proteins traverse the bilayer membrane through 
interactions with the hydrocarbon chains of the membrane and the hydrophobic domain of the 
proteins.  
Detergents form micelles through the aggregation of detergent molecules into organized 
spherical structures. At low concentrations, detergents exist as monomers and incorporate into 
the lipid bilayer, but as the concentration increases a threshold is reached called the critical 
micelle concentration (CMC) where the lipid membrane bilayer is disrupted and lysed, 
producing lipid-protein-detergent micelles. In this micelle, the hydrophobic regions of membrane 
proteins are surrounded by the hydrophobic chains of the detergent molecules and membrane 
phospholipids.  
Detergents are classified into three main categories based on the property of the 
hydrophilic head group (114, 115): non-ionic, ionic, and zwitterionic. Non-ionic detergents 
contain uncharged hydrophilic head groups and are suited for breaking lipid-lipid and lipid-
protein interactions. Non-ionic detergents are considered a non-denaturant and are widely used in 
proteomics literature for isolating membrane proteins in their biologically active form retaining 
native subunit structure, enzymatic activity or non-enzymatic function. Ionic detergents contain a 
head group with a net charge that can be either negative (anionic) or positive (cationic). Ionic 
detergents either contain a hydrocarbon straight chain as in SDS or a more complicated rigid 
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steroidal structure as in sodium deoxycholate. Ionic detergents can disrupt protein-protein 
interactions along with lipid-lipid and lipid-protein interactions, and they may denature proteins. 
Zwitterionic detergents offer combined properties of ionic and non-ionic detergents. For 
example, CHAPS does not possess a net charge like non-ionic detergents but is able to break 
protein-protein interactions like an ionic detergent. In proteomics literature CHAPS is considered 
to denature proteins less than ionic detergents possibly due to its rigid steroid ring structure.  
To summarize, there are many different detergents that may be used in decellularization 
protocols each with their own unique set of properties. For example, SDS is an ionic detergent 
that is known to denature proteins in the proteomics literature (114-116), but it is a commonly 
used detergent in the decellularization of hearts (60, 65, 66, 72). Thus, it is critical to understand 
how different detergents with distinct chemical properties effect ECM scaffolds in the process of 
decellularization. 
1.6 MOTIVATION 
ECM scaffolds offer a promising opportunity to repair an infracted myocardium that may lead to 
heart failure over time. Decellularization of tissues to produce ECM scaffolds is a complex 
process that is not standardized even for a specific anatomic source tissue. To achieve 
decellularization there are numerous reported protocols with differences in decellularization 
agents, their sequence and duration of application, and method of delivery. Depending on the 
processing methodology the host response to the implanted ECM scaffold may either be 
characterized by chronic inflammation, fibrotic encapsulation, and scar tissue formation or a 
constructive remodeling response with the formation of site-specific functional tissue. A review 
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of the properties of different types of decellularization agents suggests that their intrinsic 
chemical properties may cause varying degrees of damage to the composition and structure of 
the resultant ECM scaffold. Damage to the composition and structure of the ECM scaffold may 
subsequently impact the host response. Some of these multiple step protocols have been 
compared (72, 103, 106-113), and it was found that differences did exist in composition, 
mechanical strength, and/or cytocompatibility of the final ECM product even if derived from the 
same source tissue.  
However, no reference exists on how each detergent may affect the properties of the final 
ECM scaffold. While some multiple step protocols have been compared, these protocols contain 
multiple detergents with differences in concentrations and incubation times. Thus, while these 
reported comparisons indicate that differences may exist between some decellularization 
protocols, any conclusion drawn could not be attributed to any single step in the multiple step 
process. Additionally, none of these reported comparisons are comprehensive. These 
comparisons of decellularization protocols only focus on a limited type of detergents or methods 
of characterization (i.e. only examined composition or mechanics). Among all these referenced 
studies only two studies compared different methods of whole organ decellularization of the 
heart and neither was comprehensive, nor attempted to isolate any variables from these multiple 
step protocols (65, 72).  
The goal of decellularization is the removal of all cellular material to prevent an adverse 
immune response and to preserve the composition, structure, or mechanical integrity of the 
remaining three-dimensional ECM. However, to date, there is no methodical evaluation of the 
effect of different detergents on the ECM scaffold to assist in the formulation of an optimized 
decellularization protocol for a tissue of interest. Without such information numerous protocols 
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have been developed from conjecture with subsequent impact on the host response to the ECM 
scaffold implant and clinical outcome of the patient. Thus, the overall objective of this thesis is 
to characterize the effect of different detergent treatments on the composition and mechanics of 
ECM, and in-vitro cell-ECM interaction. This information will facilitate informed decision 
making regarding decellularization protocols and their effect upon the ECM scaffold material.  
1.7 SPECIFIC AIMS 
Specific Aim 1: To acquire a quantitative understanding of ECM micromechanics. 
Rationale: Before characterizing ECM scaffolds as a function of different detergent 
treatments the native structure of the heart and the complex interactions between the cells and 
ECM need to be assessed. The native heart valve was used due to its inherently fibrous 
architecture which is similar to an ECM scaffold.  
 
Hypothesis: Cell – ECM interaction as measured through deformation is distinct for both the 
type of valve and the layers of the valve.  
 
Specific Aim 2: To determine whether the composition, structure, and mechanics of ECM 
scaffolds are altered as a function of different detergent treatments. 
Rationale: Numerous decellularization protocols are reported in the literature with 
differences in detergents, method of detergent delivery, and durations of detergent 
application. It is unknown what effect each type of detergent has on the resultant ECM 
scaffold. In this aim the effect of commonly used detergents for decellularization is assessed 
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under equivalent conditions to develop a comprehensive profile of each detergent for 
decellularization. Two source tissues were chosen for their relevance in application to cardiac 
repair. 
 
Hypothesis: Ionic detergent treatment will result in a loss of ECM constituents, and a 
decrease in mechanical strength that will be correlated at the micro-structural scale. 
 
Specific Aim 3: To determine if cell-ECM interaction is dependent upon the detergent treatment. 
Rational: It is unknown whether the integrity of the ECM ligand – cell integrin interaction is 
retained depending on the detergent used to achieve decellularization. Modifications to the 
composition and structure that are investigated in Specific Aim 2 may correlate with 
cytocompatibility in this aim. 
 
Hypothesis: Non-ionic detergents will retain the structure and composition of ECM for a 
higher level of cytocompatibility. 
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2.0  NATIVE HEART ECM MICROMECHANICS 
Critical to the success of an ECM scaffold cardiac patch is the ability to support tissue driven 
mechanotransduction, i.e., translation of organ level mechanical stimuli into cellular responses 
through the localized fiber network. Mechanical forces were found to be critical to the 
constructive remodeling of an SIS ECM scaffold in an Achilles tendon repair in a rabbit model. 
Specifically, rabbits with full range of motion had an associated greater cellular infiltrate and 
organized connective tissue with deposition along the lines of stress compared to those whose 
motion was not constrained (117). Further, in a canine partial cystectomy model repaired with 
either SIS or UBM ECM scaffold it was found that only the bladders that had site appropriate 
mechanical loading (i.e. bladder filling) had a constructive remodeling response (118). This 
constructive remodeling response was characterized by the formation of a differentiated 
urothelium and islands of smooth muscle cells. Bladders whose fillings were inhibited with long 
term catheterization were instead characterized by fibrosis.  
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An in-vitro study also supported the idea that mechanical forces are critical to the 
promotion of a constructive remodeling response. Fibroblast seeded onto an SIS ECM scaffold 
and subjected to cyclic stretching had increased expression of Col I, exhibited a contractile 
phenotype with increased expression of SMA, TN-C, and TGF-β1 (45), and had fiber alignment 
along the axis of loading (119). Prior to investigating whether certain detergent treatments may 
damage the ECM scaffold fiber network such that it is unable to transmit organ level mechanical 
stimuli into host cellular responses, it is first critical to understand the complexity of this cell-
ECM fiber network coupling for the native heart tissue.  
Mechanotransduction is known to be critical in the control of heart form and function 
through regulation of cardiomyocyte gene expression, muscle mass, and phenotype (99). The 
native heart myocardium contains dense striated muscle unlike ECM scaffolds which are 
decellularized. The native heart valves, however, are passive elements that are composed of a 
dense multilayered ECM framework that lack this striated muscle. Thus, the native heart valves 
were investigated due to their inherently fibrous architecture similar to ECM scaffolds. To better 
understand native tissue complexity the heart valves’ micromechanics are examined in two 
stages. The first stage compares two different heart valves in terms of cellular gene expression 
profile and fiber kinematics. The second stage examines fiber kinematics in more detail with a 
focus on cell-fiber interactions. The information derived from this aim will demonstrate the 
complexity of the native heart tissue to elucidate the benefits of a tissue engineered approach to 
heart repair that utilizes site-specific ECM scaffolds. 
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2.1 GENE EXPRESSION AND COLLAGEN FIBER MICROMECHANICAL 
INTERACTIONS OF THE SEMILUNAR HEART VALVE INTERSTITIAL CELL1 
2.1.1 Introduction 
The aortic (AV) and pulmonary (PV) heart valves, termed “semilunar” due to their leaflet shape, 
have the basic function of preventing retrograde blood flow into the ventricles during diastole. 
Valve mechanical function spans multiple length scales from the organ-scale hemodynamic 
phenomena to the underlying tissue and cellular components (120). Both the AV and PV 
experience significant in-plane tension resulting from transvalvular pressure (TVP) during 
diastole (120); approximately 90 mmHg and 15 mmHg for the AV and PV, respectively. As a 
result of this difference, the AV and PV ECM organization and concomitant mechanical 
properties differ considerably (121-123). Normal tissue morphology and function rely upon the 
constituent cell population’s ability to detect forces appropriate to their correct tissue context 
(124). However, it is not known whether the AV and PV valvular interstitial cell (VIC)-tissue 
mechanical coupling and VIC function for each valve are also distinct. A better understanding of 
the anatomical site-specificity of native heart tissue is critical to understanding the requirements 
for a tissue engineered repair or replacement.  
The semilunar valves consist primarily of three histologically distinct fibrosa, spongiosa, 
and ventricularis layers, except in the coaptation region that is a single collagenous layer (125). 
The fibrosa is oriented towards the associated artery and is composed mainly of a dense, highly 
                                                 
1This work has been adapted from the following published manuscript:  
Carruthers CA, Alfieri CM, Joyce EM, Watkins SC, Yutzey KE, Sacks MS. Gene expression and collagen 
fiber micromechanical interactions of the semilunar heart valve interstitial cell. Cellular and Molecular 
Bioengineering. 2012;5(3): 254–265.  
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aligned network of Type I collagen fibers. For the AV the fibrosa layer dominates the 
mechanical response compared to the ventricularis layer (126). The ventricularis faces the 
ventricle and is composed primarily of elastin and a more loosely structured collagen fiber 
network. The spongiosa, located between the fibrosa and ventricularis, is rich in 
glycosaminoglycans, and has been observed to have collagen fibers transverse it that 
interconnect the fibrosa and ventricularis layers (126). Structural adaptations to applied stress, 
especially in the collagen fiber network, are also distinct for each valve (122). In the unloaded 
configuration, the AV leaflet demonstrates substantial regional variations in collagen fiber 
alignment as compared to the relatively uniform PV (122). As loading commences, the AV 
collagen fibers straighten more than observed for the PV (122). These differences in valvular 
tissue structure also are apparent in the mechanical behavior under biaxial load at aortic 
physiological membrane tension (60 N/m) (123), where the PV is more compliant in the radial 
direction compared to the AV, while both valves respond similarly in the circumferential 
direction (123). 
Clinical interest for the PV has focused on auto-transplantation into the aortic position as 
a replacement for the AV, especially for the pediatric population (127). This results in a six-fold 
increase in the PV autograft TVP, with explants from 2-10 weeks having a higher VIC 
biosynthetic activity compared to explants from 3-6 years (128). These results suggest that the 
PV autograft can adapt to the increased loading at the cellular level, possibly until a new 
homeostatic state is achieved although such information is lacking. Moreover, the development 
of engineered tissue approaches to congenital PV and AV reconstruction require a detailed 
knowledge of semilunar heart valve mechanics and the underlying mechanobiology.  
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VICs maintain the ECM structure through protein synthesis and enzymatic degradation 
(129), and are phenotypically plastic in that they are quiescent under homeostatic conditions and 
active in periods of growth and disease (130). Yet, relatively little is known about how organ 
level mechanical stimuli result in alterations in semilunar valve biosynthetic activity. Both in our 
and other laboratories cyclic mechanical stimuli during in-vitro culture has been utilized in 
valvular tissues to elicit alterations in biosynthetic activity (131, 132). These results suggest a 
link between the VIC phenotype, biosynthetic activity, and cellular loading resulting in the 
specific valve in-vivo hemodynamic environment. These studies were directed in part towards 
understanding how changes in TVP induce concomitant changes in structural and mechanical 
properties of the AV and PV in-vivo. Along these lines, the porcine AV VICs undergo larger 
deformations in the fibrosa layer compared to the spongiosa and ventricularis layers (133).  
The above results clearly suggest specific VIC-ECM interactions that may be also unique 
for each semilunar valve, including layer-specific adaptations. To gain insight into this question, 
this sub-aim quantitatively links the semilunar valve VIC biosynthetic activity at the genetic 
level to differences in VIC location (valve type, layer), VIC deformation level, and VIC 
quantitative mechanical interactions with the collagen fiber network with TVP. VIC mRNA 
expression level of ECM constituents and phenotypic markers was measured with qRT-PCR 
from both semilunar valves. Changes in VIC shape were quantified using semilunar valves 
exposed to increasing TVP, and compared to differences in valve ECM layer structure and 
collagen fiber structure. Note for the PV both physiologic (~15 mmHg) and hyper-physiologic 
(~90 mmHg) TVP levels were utilized in order to compare both its physiological and autograft 
environments.  
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2.1.2 Methods 
2.1.2.1 Histomorphometry  
Porcine hearts (from animals 10 months old, and approximately 250 lbs) were obtained within 10 
minutes of death from a local USDA approved abattoir (Thoma Meat Market, Saxonburg, PA). 
AV and PV leaflets were dissected on site, with the surrounding myocardium trimmed from the 
leaflets. A central 2 mm strip in the radial direction was removed and fixed in 10% neutral 
buffered formalin (VWR) for histology. The remaining leaflet was frozen in liquid N2 and stored 
at -80oC prior to homogenization for mRNA analysis. 
The resulting formalin fixed leaflet tissue was processed as previously described (134, 
135). Briefly, Movat's modified pentachrome staining was used to visualize fibrous collagen 
(yellow), proteoglycan and GAGs (blue), and elastic fibers (black), on 5 µm sections on the 
radial-transverse surface (Figure 1). Leaflet thickness, as well as the percent total thickness of 
fibrosa, spongiosa, and ventricularis layers were evaluated in 3 regions per leaflet for n=7 AV 
and n=7 PV leaflets using ImageJ software. Leaflet layers were identified by distinct color boundaries whereby the fibrosa layer contained yellow and blue, the spongiosa layer contained blue with no black or yellow, and the ventricularis layer contained only black. 
Statistical significance of differences between AV and PV dimensions was determined by 
independent-samples t-test with p<0.05, with values reported as mean ± standard error. 
2.1.2.2 Real-Time Quantitative PCR  
Porcine AV and PV leaflets were obtained as above and frozen in liquid N2 then stored at -80oC 
prior to homogenization and total RNA isolation using Trizol as previously described (136). 
Samples were then treated with DNase using a DNA-free kit (Invitrogen). RNA was quantified, 
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and 0.5 µg was used for cDNA synthesis with the Superscript RT-PCR kit according to 
manufacturer's instructions. 1µL cDNA was used for real-time PCR by Taqman gene expression 
assays and the StepOnePlus system (Invitrogen).  
Taqman assays used were porcine GAPDH (Ss03373286_u1), Col1a1 (Ss03373340_m1), 
Col3a1 (Ss03375691_g1), Hsp47 (Ss03373335_g1), matrix gla protein (MGP) 
(Ss03394091_m1) and biglycan (Ss03375454_u1). An additional custom assay was designed for 
porcine periostin (forward 5'-GGCAAACAGCTCAGGGTCTTC-3'; reverse 5'-
TTCCTCTAACCATGCATGAATTTTC-3'; probe 6FAM-TGTATCGTACTGCTGTCTG-
MGBNFQ). The identity of the amplified periostin DNA fragment was confirmed by 
sequencing. Taqman assays were used at 1X and custom assays were performed using 900 nM 
forward and reverse primers with 250 nM probe. Amplification conditions were step 1 95oC 20s; 
step 2 95oC 1s; step 3 60oC 20s, with steps 2 and 3 repeated for 40 cycles. All amplifications 
were performed in triplicate for each sample and data were normalized to GAPDH levels. 
Relative expression values also were determined based on normalization to β-actin 
(Ss03376563_uH) expression, and no significant differences were observed for expression 
values normalized to either GAPDH or β-actin.  
Data were analysed using the comparative ∆∆Ct method according to manufacturer's 
instructions (Invitrogen). Expression values for each leaflet were reported relative to the AV 
from the same animal, set at 1.0. A total of 15 AV and 15 PV leaflets from 5 individual AV and 
PV were evaluated. Statistical significance for each marker of interest between AV and PV was 
determined by a paired samples t-test with p<0.05 (PASW Statistics, V. 18). Values are reported 
as mean ± standard error. 
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2.1.2.3 Tissue Level Biomechanics 
Porcine PV leaflets used for biomechanical analysis were removed from the pulmonary root 
using aforementioned tissue source and preparation protocols. The right PV leaflet was chosen 
for this study for consistency and placed in gauze wet with PBS and snap frozen at -80 °C to 
avoid tissue degradation prior to testing (137). A detailed description of the biaxial testing device 
and methods used for planar biological tissues has been reported previously (138). A 10 mm x 10 
mm section was dissected from the central belly region of the leaflet. Specimens were 
preconditioned ten cycles with a half cycle time of 15 s to a maximum membrane tension of 60 
N/m. A peak tension of 60 N/m was used because it corresponds to an in-vivo aortic diastolic 
pressure of approximately 90 mmHg (138, 139). Eight right PV leaflets from eight pig hearts 
were tested. Samples were compared to previously tested right coronary AV leaflet samples from 
seven pig hearts (126). The average biaxial response of the AV was compared to the PV by 
performing a linear interpolation on each sample at representative tension values and averaging 
the interpolated stretch values across samples at each tension. Max AV circumferential stretches 
were compared to max PV circumferential stretches with an independent-samples t-test with 
p<0.05 (PASW Statistics V 18). Values are reported as mean ± standard error.  
2.1.2.4 Valve Deformation and VIC-ECM Imaging  
All AV and PV tissue sections were acquired from a previous study by Joyce et al., as described 
in (122). In brief, pairs of AVs and PVs were fixed at retrograde hydrostatic pressures of 
0,1,2,4,10,20,60, and 90 mmHg in aqueous glutaraldehyde solution using an elevated reservoir 
column. The application of retrograde pressure mimicked diastole when the leaflets coapted and 
underwent a large planar distention. For each pressure level and valve, the belly region of one of 
the three leaflets (Figure 1) was paraffin embedded, and two 5 μm sections were taken and 
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stained with Movats Pentachrome to distinguish VIC nuclei and the three leaflet layers: Fibrosa, 
spongiosa, and ventricularis (122, 133). Additional 5 μm sections were stained with Picrosirius 
red and imaged under polarized light microscopy, as previously described, to visualize the 
natural birefringence of collagen fibers by the periodic bands that correspond to collagen fiber 
crimp (122). Additional sections were taken at 30 μm for 3D analysis at pressures of 0 and 90 
mmHg for the AV to represent both the free float and physiological TVP, respectively, and 0, 20, 
and 90 mmHg for the PV to represent free float, physiological TVP, and hyper-physiological 
TVP (in the case of the Ross procedure), respectively. 
Each section was deparaffinized, permeabilized with Triton™ X-100 for 20 minutes at 
1:1000 concentration, stained with Sytox green nucleic acid stain (Invitrogen) for 1:2000 for 15 
minutes, and gelvatol mounted with a coverslip for two-photon microscopy (TPM) (140). TPM 
was executed with an Olympus FV1000 TPM system equipped with a Chameleon ultra diode-pumped laser operated with Olympus fluoview software. TPM was used to 
simultaneously image collagen and VIC nuclei via second-harmonic generation (SHG – filter set 
at 400±100 nm) and two-photon excited fluorescence (TPEF – filter set at 525±50 nm), 
respectively. Each sample was imaged with a 25x XL Plan N objective (N.A. of 1.05) forming a 
500 by 500 μm field of view with a 0.5 μm/pixel resolution to a subsurface z-axis depth of 25-30 
μm with a 1 μm step size resulting in 25-30 images composing a stack. An excitation wavelength 
of 830 nm was used for all samples with a laser transmissivity of 7%. Image stacks were 
reconstructed into 3D projections for a localized volume (Figure 5b) using VOXX (Indiana 
University Medical Center, Indianapolis, IN, USA), a freeware voxel-based volume-rendering 
program. 
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2.1.2.5 Determination of Nuclear Orientation and Deformation 
In the present sub-aim, VIC nuclear orientation and deformation states were measured between 
the valves as a function of layer and TVP. Preliminary orientation information was acquired 
from the TPM image stacks, which were imported into a custom Matlab program (The Math-
Works, Natick, MA) to acquire the 3D point cloud of each nucleus, from which principle 
component analysis (PCA) was performed on the segmented VIC nuclei to acquire the 3D 
nuclear orientation (Figure 6a-b) (141). On average, ~300 VICs were counted per sample. To 
distinguish the layers in the TPM images, the collagen content derived from the SHG signal was 
utilized. Specifically, it was found that the spongiosa layer had minimal collagen fiber content as 
compared to the fibrosa and ventricularis layers. The fibrosa layer was easily distinguished due 
to its high collagen content, direction, and thicker size. This observation was confirmed to match 
the Movat’s Pentachrome stain.  
2D analysis of VIC nuclear aspect ratio (NAR) is a sufficient and robust measure of total 
VIC deformation (120, 133). Thus, in the present sub-aim additional 2D analysis of VIC 
deformation was performed on the AV and PV as a function of spatial location and TVP to 
extend previous studies on the AV (133). Briefly, using Movat’s pentachrome stained sections in 
the transverse-circumferential plane (131, 132), a panoramic image was created from one to five 
overlapping images in order to span the complete thickness of the leaflet (including fibrosa, 
spongiosa, and ventricularis). This process was repeated for approximately five different 
locations across the section. The nuclei were identified, spatial locations recorded, and nuclear 
aspect ratio (NAR, ratio of the longest to shortest axial lengths) determined. The NAR has been 
shown to be an accurate index of VIC deformation, with NAR determined in the transmural-
circumferential plane (Figure 1). Approximately 60 VICs were counted per panoramic image 
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across five locations of each leaflet, resulting in 300 VIC counted per pressure level. Statistical 
analysis for each TVP was determined using an independent-samples t-test at p<0.05 (PASW 
Statistics, V. 18). Values are reported as mean ± standard error. 
2.1.2.6 Relation of VIC Deformation to Tissue Stress Level 
The observed changes in NAR were clarified to estimated local tissue stress levels. The average tissue and fibrosa layer Cauchy stresses, σ, was approximated using the Laplace relation 
σ=½PR/t, P is the TVP, R is the current radius of curvature, and t is the current thickness. The 
deformed semilunar heart valves shape was approximated assuming a spherical geometry with a 
radius of curvature of 10 mm (138, 139). For the thickness both the fibrosa and total thickness of 
the AV and PV were utilized in the deformed configuration to bracket the estimated stress range. 
While this assumption of a constant singular radius of curvature does not account for the 
transverse isotropy of the heart valve, the Laplace relation provides a first approximation of the 
Cauchy stresses. 
2.1.3 Results 
2.1.3.1 Structural Differences between the AV and PV Leaflets 
In both leaflets the collagen-rich fibrosa, proteoglycan-rich spongiosa, and elastin-rich 
ventricularis layers were clearly evident (Figure 1). The overall AV and PV leaflet thickness in 
addition to the relative thickness of fibrosa, spongiosa and ventricularis layers were quantified 
morphometrically (Table 2). Overall, the AV leaflets were confirmed to be significantly thicker 
than the PV leaflets. Comparison of the average thicknesses for the fibrosa layer confirmed that 
the AV fibrosa layer was twice as thick as the PV leaflet fibrosa layer, as previously reported 
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(122). However, the PV leaflet was not simply a scaled down version of the AV leaflet. The 
relative thickness of the fibrosa layer of the AV was greater than that of the PV, while the 
relative thickness of the spongiosa layer of the PV was greater than that of the AV (Table 2). The 
relative thickness of the ventricularis layer of the AV and PV leaflets was approximately the 
same for both valves. Hence, on a per layer basis it was confirmed that the overall thickness of 
the AV leaflet was not only higher than the PV leaflet but the relative layer proportions were also 
distinct with the fibrosa being thicker for the AV and the spongiosa being thicker for the PV. 
 
Figure 1: Histological assessment of porcine AV and PV leaflet stratification. F, S, and V represent 
the fibrosa, spongiosa, and ventricularis, respectively. Relative thickness of the valve ECM layers is indicated 
by brackets. A partially polarized image of an aortic valve leaflet is also included where C and R represent 
circumferential and radial direction, respectively.  
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Table 2: Morphometry of AV and PV stratification. Layer thickness was measured from Movat’s 
Pentachrome images. Calculations of % relative thickness were made from layer thickness/total thickness. 
Values are reported as mean ± standard error of mean (n=7). Statistical significance of differences between 
AV and PV dimensions was determined by an independent student's t-test (*p<0.05). V represents 
ventricularis, S represents spongiosa, and F represents fibrosa. 
  Total (µm)* V (µm)* S (µm) F (µm)* V/Total (%) S/Total (%)* F/Total (%)* 
AV  446 ± 24 111 ± 9 140 ± 16 194 ± 13 25 ± 1 30 ± 2 45 ± 3 
PV 282 ± 17 68 ± 5 118 ± 13 96 ± 6 25 ± 1 41 ± 3 35 ± 2 
2.1.3.2 Tissue-Level Biomechanical Differences between the AV and PV 
The equi-biaxial tension responses of both semilunar valve leaflets were similar (Figure 2). Both 
valves followed similar transitions in the radial direction from a low modulus region to a high 
modulus region. In the circumferential direction both valves had an immediate high modulus 
with minimal stretch. In the radial direction both valves were compliant with a nonlinear 
response. The PV was significantly more extensible than the AV in the radial direction reaching 
a maximum stretch of 1.84 ± 0.10 compared to the AV maximum stretch of 1.56 ± 0.05.  
 
Figure 2: Mechanical characterization of the porcine AV and PV leaflet belly region with a planar 
biaxial test.  
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2.1.3.3 Differential Expression of ECM Genes in AV and PV  
The mRNA expression levels of genes corresponding to ECM constituents present in all the 
leaflet layers of the porcine AV and PV were evaluated. Expression of the major load bearing 
fibrillar collagens Col1a1 and Col3a1 was determined, in addition to the expression of the 
molecular chaperone Hsp47, which is an indicator of collagen biosynthesis (142, 143). Biglycan 
was assessed as an indicator of proteoglycan gene expression, based on its expression in all 
layers together, with filamentous strands in the spongiosa layer (143). Previous studies have 
indicated differential expression of MGP that serves a protective role in calcification, with higher 
expression in porcine VIC isolated from PV relative to AV (144). Expression of periostin, 
demonstrated to have a role in collagen fibrillogenesis and aortic valve disease, also was 
assessed (145). Col1a1, Col3a1, Hsp47, and Biglycan expression levels were significantly 
increased in the AV versus PV (Figure 3). Periostin was expressed at similar levels in AV and 
PV (Figure 3), as previously reported (143, 145). The higher level of MGP expression in AV 
compared to the PV was distinct from what was observed in cultured VIC (Figure 3b). 
 
Figure 3: (A) Differential ECM constituent gene expression in porcine AV and PV, and (B) 
differential gene expression of VIC phenotypic markers was detected by qRT-PCR (*p<0.05). 
38 
2.1.3.4 Differences in VIC Deformations as a Function of Valve Layer  
From visual inspection of circumferential-transverse sections stained with Movat’s Pentachrome 
stain (Figure 4) both the AV and PV total thickness decreased as a function of pressure. At 0 
mmHg, undulations present in the fibrosa layer represented the crimp pattern of the collagen 
fibers under low tension; the VICs appeared to have a similar circular shape throughout the three 
layers. As the pressure increased to 90 mmHg, the undulations were no longer present in the 
fibrosa layer as the collagen fibers are fully loaded (For visualization of this crimp under 
Picrosirius red stain, see (122) Figure 7a-b). At 90 mmHg, the VICs in the fibrosa layer were 
mechanically compacted and elongated with an ellipsoidal shape between organized collagen 
fibers while the VICs in the spongiosa and ventricularis layer still were fairly circular.  
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Figure 4: Histological assessment of circumferential-transverse sections of porcine AV and PV leaflet 
tissue stratification and VIC deformation as a function of low and high pressure under Movats pentachrome 
stain.  
A localized 3D reconstruction of the AV collagen fibril organization and VIC nuclei as a 
function of the layer and physiological pressure from TPM imaging of a 30 μm circumferential 
transverse section (Figure 5) confirmed visual observations of layer dependent VIC deformations 
with pressure from 5 μm circumferential transverse sections stained with Movat’s Pentachrome 
(Figure 4). At 0 mmHg for the fibrosa layer, the collagen fibers were undulated and oriented in 
the circumferential direction. At 0 mmHg, the VIC nuclei exist above, below and between the 
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collagen fibers, conforming to the fibers’ natural undulations, and were ellipsoidal in shape. 
Although collagen was present in the spongiosa and ventricularis layer, the collagen fibers were 
not organized into large fibrous bundles with a distinct orientation. Compared to the fibrosa 
layer, the spongiosa and ventricularis layer have large areas without collagen, which may contain 
other ECM constituents. 
At 90 mmHg, the collagen fibers were straightened with a decrease in crimp period and 
amplitude. The space between the fibers was decreased. The VIC nuclei were decreased in 
sphericity, and were mechanically compacted between the fibers while elongated in the space 
along the fibers in the circumferential direction. VICs had a higher degree of compaction in the 
circumferential-transverse plane compared to the circumferential-radial plane, indicating that the 
spacing between the collagen fibers was smaller in the circumferential-transverse plane. At 90 
mmHg, the VIC nuclei in the spongiosa and ventricularis layer do not deform along the 
circumferential direction. The VICs in the spongiosa and ventricularis layer may not deform with 
pressure because of the lack of oriented collagen fibers to mechanically compact nearby VICs. 
Thus, VIC deformation mainly occurred in the fibrosa layer likely due to mechanical compaction 
by nearby collagen fibers. 
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Figure 5: (A) Collagen fibers of a cross-section of the AV leaflet in the circumferential-transverse (C-
T) plane (see Figure 1 line label 2) with the fibrosa (F), spongiosa (S), and ventricularis (V). The section was 
visualized with second harmonic generation (SHG) from TPM microscopy. The white boxes indicate the 
regions used for the 3D reconstruction in (B). (B) TPM microscopy was used to simultaneously image AV 
collagen (red) and cell nuclei (green) for a 60x80x20 μm localized volume, via SHG and two-photon excited 
fluorescence, respectively. C, R, and T represent circumferential, radial and transverse direction, 
respectively. 
To confirm the visual observation that VICs were oriented along the circumferential 
direction in the fibrosa layer, a preliminary measurement of VIC 3D nuclear orientation was 
completed from TPM of 30 μm circumferential transverse sections at physiological TVP for both 
the AV and PV. Overall, the preferred nuclear direction was along the circumferential direction 
in the circumferential-radial plane, as evidenced by the centroid of θ and Ф at approximately 
9.7±2.8° and 5.3±4.1° for all measured nuclei for both the AV and PV (Figure 6a,b). For θ 
(Figure 6c) there was an increase in alignment for the nuclei in the fibrosa layer of the PV while 
the nuclear alignment of the AV remained relatively constant. In the spongiosa and ventricularis 
layer, for θ there was a decrease in overall alignment with load for both the AV and PV. For Ф 
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(Figure 6d) there was a substantial increase in alignment for both the AV and PV in the fibrosa 
layer, but a decrease or relatively constant alignment in the spongiosa and ventricularis layers. 
For the fibrosa layer of the PV, the majority of cellular realignment for both the θ and Ф 
directions and the majority of fiber realignment occurred by 20 mmHg, the PV physiological 
TVP (Table 3).  
Thus, VIC nuclear orientation in the fibrosa layer correlated with collagen fiber 
alignment. Although VIC nuclear deformation correlates with collagen fiber alignment, this is 
not the only factor contributing to VIC deformation. The nuclei normalized orientation index 
(NOI) for θ (Table 3) in the PV fibrosa layer continued to increase alignment along the 
circumferential direction in the circumferential-radial plane after physiological TVP at 20 
mmHg, although the NOI remained constant after 20 mmHg. Further, the nuclei NOI was higher 
than the collagen fiber NOI. This indicated that after the majority of collagen fibers align, the 
nuclei still underwent further deformation and were actually more aligned than the fibers. This 
confirmed visual observations (Figure 4, Figure 5) that the mechanism of VIC deformation was 
mechanical compaction, not just collagen fiber organization.  
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Figure 6: (A) 3D nuclear geometries were acquired and principal axes directions (e1,e2,e3) were 
found. (B) The major principal axis (e3) was defined in spherical coordinates from angles θ and Ф as a 
function of the 3D tissue coordinate system. (C) Nuclei angle distribution for θ and (D) Ф was assessed as a 
function of physiological and hyperphysiological pressure. Frequency is normalized by area in radians. 
Figure legend represents pressure in mmHg. F represents fibrosa layer, and S+V represents the combined 
spongiosa and ventricularis layer.  
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Table 3: 3D VIC nuclear orientation for the semilunar leaflet layers. The normalized orientation 
index (NOI) for θ represents nuclei alignment, and the NOI for small angle light scattering technique (SALS) 
represents the ECM fiber alignment. AV and PV represent aortic valve and pulmonary valve, respectively. F, 
S, and V represent fibrosa, spongiosa, and ventricularis, respectively. Values are reported as mean ± 
standard error. 
 Nuclei - θ NOI (%) SALS NOI (%) 
 AV PV AV PV 
TVP F+S+V F S+V F+S+V F S+V F+S+V 
0 75.6 75.6 73.3 66.7 71.1 57.8 50.8±0.9 36.3±2.4 
20 NA 57.8 75.6 13.3 62.4±1.5 59.4±2.1 
90 57.8 73.3 33.3 46.7 80.0 24.4 62.0±1.3 60.3±1.1 
2.1.3.5 Differences in VIC Deformation between the Semilunar Valves 
As VICs were oriented along the circumferential direction in the circumferential-radial plane, we 
were able to simply the NAR deformation analysis to 2D in evaluating valve-specific 
differences. The NAR was found to be both layer- and valve-dependent as a function of TVP 
(Figure 7). At 0 mmHg the VIC NAR was between 2.0-2.5 (i.e. moderately ellipsoidal as 
compared to a spherical value of 1.0). The AV and PV fibrosa layer NAR did not change from 0 
to 2 mmHg, but from 2 mmHg to 4 mmHg NAR in both valves experienced a similar rapid 
increase. At 4 mmHg the PV NAR continued to increase at a more gradual rate, exceeding the 
rate of increase of the AV NAR. By 60 mmHg, the AV NAR achieved a plateau while the PV 
NAR continued to gradually increase.  
Interestingly, under diastolic loading, the AV fibrosa NAR (90 mmHg diastolic TVP) 
was similar to the PV fibrosa NAR (18 mmHg diastolic TVP) at approximately six. The AV and 
PV spongiosa and ventricularis layers combined had a similar modest but significant increase in 
NAR from 0 to 10 mmHg, and then remained constant from 20 to 90 mmHg reaching a NAR of 
2.47±0.07 and 2.67±0.08, respectively (not statistically different). There were minimal 
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differences between the trends of the separated spongiosa and ventricularis layers compared to 
the combined spongiosa and ventricularis. At a TVP level of 90 mmHg, mimicking the pressure 
that the PV experiences in the Ross procedure, the PV fibrosa reached a NAR of 9.67±0.61 that 
was significantly greater than the AV fibrosa NAR of 5.95±0.27. This difference in VIC 
deformation in the fibrosa layer is also visually confirmed (Figure 4). Hence, the AV and PV 
have complex nonlinear layer-specific VIC NAR as a function of pressure. 
 
Figure 7: NAR of the porcine AV and PV as a function of TVP and layer. F represents fibrosa, and 
S+V represents combined spongiosa and ventricularis layer. An increase in NAR represents an increase in the 
VIC nucleus deformation. The vertical dashed lines denote approximate diastolic TVP of the AV and PV, 
while the horizontal dashed line represents the similar NAR at these respective TVP. 
VIC mechanical coupling to collagen fibers in the fibrosa layer for both the AV and PV 
was further examined by comparing VIC deformations to collagen fiber straightening (Figure 8). 
As the TVP increased, the observable straight collagen fiber area increased. The increase in 
observable straight collagen fiber area was more rapid for the AV compared to the PV, and the 
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range of observable straight collagen fiber area was larger for the AV compared to the PV 
(Figure 8a). The NAR of the VICS in the fibrosa layer of the AV and PV also correlated with 
observable straight collagen fiber area as a function of TVP (Figure 8b). From 0% to 70% 
observable straight collagen fiber area there was relatively little change in VIC NAR. Above 
70% observable straight collagen fiber area, corresponding to approximately 4 mmHg, there was 
a rapid increase in NAR for the PV compared to the AV. Further, at pressures above 4 mmHg the 
PV has a higher NAR and a lower observable straight collagen fiber area compared to the AV. 
At 90 mmHg both the AV and PV have approximately 93% observable straight collagen fiber 
area, but the PV reached a NAR of 9.67 and the AV reached a NAR of 5.95. This valve-specific 
correlation between VIC deformation and observable collagen fiber straightening indicated that 
VIC deformation was specific to the unique mechanical interactions within each valve’s collagen 
fiber network. 
 
Figure 8: (A) Observable straight collagen fiber area from percent total area as a function of TVP. 
(B) NAR of the AV and PV fibrosa (F) was assessed as a function of both observable straight collagen fiber 
area from percent total area and TVP.  
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 NAR of both valves were closer in value at equivalent stresses (Figure 9) compared to 
equivalent TVP (Figure 7) regardless of which stress metric was utilized, but were still 
surprisingly distinct for each valve. Specifically, the AV was under three to six times higher 
stress than the PV at their respective diastolic TVP assuming that either the fibrosa (Figure 9b) or 
the entire thickness (Figure 9a) bore the load. Thus, the VIC NAR was also a unique function of 
the local tissue stress within each valve.  
 
Figure 9: NAR of the AV and PV fibrosa (F) layer as a function of Cauchy stress. TVP was converted 
to stress through Laplace’s law to account for difference in the deformed thickness. (A) It was assumed that 
the total thickness bears the load. (B) It was assumed that the thickness of only the fibrosa layer bore the 
load.  
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2.1.4 Discussion  
2.1.4.1 ECM Gene Expression and the Organization of the AV and PV 
This sub-aim demonstrated clear structural and functional differences, from the macro to the 
micro scale, between the semilunar valves. At the macro scale, the ECM stratification is valve 
specific, with the AV having a greater total and fibrosa layer (both absolute and proportional) 
thickness compared to the PV (Figure 1) (122). The fibrosa layer is predominantly composed of 
dense, type I fibrillar collagen that provides the large structural resilience required by the valve 
to resist the TVP. Thus, the finding that the AV has a thicker fibrosa layer (both in terms of 
absolute measurement and relative to the total thickness) is not surprising as its diastolic TVP 
that is six times greater than the PV. Moreover, we estimated larger tissue stresses at diastole in 
the AV (either total or by the fibrosa layer only, Figure 9). While based on a simple Laplace law 
approximation, this finding suggests that the thicker AV fibrosa does not fully compensate for 
the increased AV TVP; the AV fibrosa tissue is actually under effectively higher stresses 
compared to the PV at their respective diastolic pressures.  These findings are consistent with the observed higher baseline collagen gene expression in 
the AV compared to the PV (Figure 3), as well as with in-vitro study on isolated VIC culture 
from all four heart valves (146) where the VICs from valves under the highest TVP (mitral and 
aortic valves) demonstrated the highest biosynthetic levels. Further, in a recent study that 
examined collagen hydrothermal stability of heart valve tissues, it was found that collagen in 
heart valves subjected to higher TVP had lower molecular stability and cross-linking (147). The 
molecular stability of the collagen in the AV also decreased compared to that of the PV from 
transition from fetal to neonatal when the TVP in the AV increases due to closure of the foramen 
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ovale and ductus arteriosus (148). Aldous et al. speculated from these findings that a relationship 
exists between the turnover rate of collagen and mechanical loading whereby there is a faster rate 
of damage accumulation and collagen turnover in the valves under higher TVP as a mechanism 
of resistance to biomechanical fatigue loading. While intriguing, these findings are at present 
correlative and further studies needed to establish specific mechanisms, such as normalization 
for any differences in total collagen protein levels and to clarify how mRNA changes correspond 
to specific changes in protein levels in valvular tissues.   
2.1.4.2  VIC ECM Layer Specific Deformation Response 
Cellular deformation has been shown to occur as a function of organ level load for both native 
tissues and engineered tissue scaffolds (133, 141, 149). Critical to understanding the 
mechanobiological response of VICs is how the collagen fiber network locally deforms VICs 
with application of organ level loads. Note further that VIC-collagen micromechanical 
interactions were investigated under increasing TVP to simulate diastolic loading because it is 
during this phase the leaflets undergo the highest strains. In contrast, during opening/closing the 
leaflets are submitted primarily to flexure, wherein the leaflets undergo large deflections but 
small strains (approximately +/- 7% strain (150)).  
In the present study, it was observed that VICs in the collagen-rich fibrosa layer 
significantly deform at higher pressures compared to the VICs in the spongiosa-ventricular layer 
that deform minimally (Figure 4, Figure 5, and Figure 7). Visual inspection of 3D image stacks 
(Figure 5) and quantification of VIC orientation and deformation (Figure 6, Figure 7, and Table 
3) suggests that VICs in the spongiosa-ventricularis layer deform minimally because of a lack of 
large organized collagen fibers. Hence, the VIC-ECM coupling in the fibrosa and spongiosa-
ventricularis layers is completely different and may have implications on VIC function in each 
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layer. The present study, taken together with our previous findings (122, 123), clearly indicates 
that the collagen fiber network organization of each semilunar valve is distinct. 
2.1.4.3 General VIC-Collagen Micromechanical Interactions 
The findings of this sub-aim indicate that VIC deformation is not a linear relationship with 
pressure (Figure 7) or tissue level deformations (Figure 2), but is instead dependent on the local 
rotation and straightening of collagen fibers (Figure 4, Figure 5, Figure 8b). Thus, these findings 
suggest that VIC deformation within the fibrosa layer is driven by changes in the local (as 
opposed to larger tissue level) collagen fiber structure as a function of TVP (Figure 8). VICs 
were found to preferentially align along the circumferential direction, which is the same as the 
preferred direction of collagen fibers. At a cell-ECM level, VICs are interconnected to the 
collagen fibers by integrins. It has been shown that blocking of the α2β1 integrin or preventing 
actin polymerization resulted in a decrease in VIC orientation in the circumferential direction 
(151). Although demonstrating that integrins are a critical component of VIC-collagen 
interaction under small loads, under physiological loads it was found that VICs in the fibrosa 
deform due to mechanical compaction of surrounding collagen fibers (Figure 8, Table 3). Thus, 
specific organ level deformations do not directly translate to cellular level deformation but are 
highly modulated by the local collagen fiber structure.  
2.1.4.4 Valve Specific Differences in VIC-Collagen Micromechanical Interactions  
The substantial differences in the highly nonlinear fibrosa AV NAR compared to the PV as a 
function of stress confirms that the VIC-collagen micromechanical interactions are 
fundamentally different between the two valves (Figure 9). At 90 mmHg the PV had 
approximately a two times greater NAR than the AV. Thus, in pulmonary hypertension or the 
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Ross procedure, where the PV is under an increased pressure, the PV VICs undergoes a greater 
deformation than the AV VICs. This increase in cellular deformation may have implications to 
the PV VIC biosynthetic state, and subsequent leaflet remodeling. The most surprising finding is 
that AV VIC and PV VIC in the fibrosa have similar NARs at their respective diastolic TVP 
(Figure 6c, Table 3). Thus the valve collagen fiber network may be organized to induce a nearly 
constant NAR at peak diastolic TVP. This finding may indicate that the semilunar valves adjust 
the fiber network organization in response to TVP and this may be an important feature in 
maintaining semilunar valve homeostasis. Moreover, from these findings it is speculated that this 
is a common feature to all heart valves. 
2.1.4.5 Summary and Implications 
Collectively, these results indicate an interrelationship between ECM organization, VIC gene 
expression, and deformation with TVP that is highly valve specific. At the tissue level, the AV 
has a thicker fibrosa layer that is also subjected to greater stresses than the PV. At the gene level, 
this is consistent with higher levels of Hsp47, Col1a1, and Col3a1 mRNA expression in the AV 
than the PV. At the cell level, VICs undergo substantially larger deformations in the fibrosa layer 
compared to the spongiosa and ventricularis layers. VIC deformation in the fibrosa layer also 
appears to be due to mechanical compaction and elongation between local collagen fibers, while 
the spongiosa and ventricularis layer do not contain large organized collagen fibers and hence 
may not be able to induce large cellular deformations. Most interestingly, at their respective 
diastolic TVP for each valve VICs have a similar magnitude of deformation, even though there is 
a 6-fold difference in pressure and the difference in stress is estimated to be between 3 and 6 
fold. Further, at 90 mmHg the PV VIC undergoes a much larger deformation than the AV VIC, 
which can be reached in pulmonary hypertension, or an autograft repair. Hence, different stress 
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levels may lead to modification of ECM gene expression and architecture, as seen with age, 
disease, or repair (121, 128, 134, 142, 148). Such anatomically site-specific complexity of the 
native heart valves through complex micro-interactions between the cell and fiber network 
indicate the potential benefits of using site-specific ECM scaffolds for a tissue engineered heart 
repair. 
2.2 MICROMECHANICS OF THE MITRAL VALVE LEAFLET FIBROUS AND 
CELLULLAR STRUCTURES UNDER PHYSIOLOGICAL LOADING 
2.2.1 Introduction 
The investigation of the aortic and pulmonary valves indicated site-specific anatomic differences 
in cellular gene expression, tissue morphology, tissue mechanics, and cell-fiber network 
coupling. In order to acquire a better understanding of this cell-fiber network coupling the mitral 
valve was investigated due to its highly complex multi-layered structure, whose ECM constituent 
content and organization underlie its gross mechanical response under the highest transvalvular 
pressure of all the heart valves (121, 130, 152, 153). Such understanding of the VIC-ECM fiber 
network coupling will help to identify if the integrity of different ECM constituents and the fiber 
network are necessary in an ECM scaffold.  
The MV leaflets are composed of the following four layers over most their volume: the 
atrialis, spongiosa, fibrosa, and ventricularis. The atrialis is composed of both type I and III 
collagen and elastin, and it is oriented towards the left atrium; the spongiosa is mainly composed 
of gycosaminoglycans; the fibrosa is the thickest layer and is composed mainly of 
53 
circumferentially oriented type I collagen; and the ventricularis is mainly composed of elastin 
and is oriented towards the left ventricle (154, 155). The circumferentially oriented collagen 
fibers of the fibrosa layer contribute to a stiffer mechanical response along the circumferential 
axis compared to the more compliant radial axis (156, 157). The large anisotropic strains found 
in-vitro through biaxial testing correspond to recent in-vivo measurements during systole (158). 
Although the valve structure has been qualitatively described in the literature, there is scant 
quantitative experimental data on how the MV fiber network reorganizes as a function of load, 
which is critical for implementation of a structural approach.  
As tissue stress is closely related to cellular and tissue homeostasis (159-164) it also 
becomes critical to gain a better understanding of the underlying valvular interstitial cell (VIC) 
population, which maintain the ECM structure through protein synthesis and enzymatic 
degradation (129, 165-167). VICs have been demonstrated to be phenotypically plastic from 
human explants, quiescent under homeostatic conditions, and active in periods of growth and 
disease (130). It has been found that VICs undergo large scale deformations with tissue level 
stress (133), and VICs have recently been found to be closely coupled to collagen fibers via α2β1 
integrins (151). Hence, organ level loads are being transferred to large scale cellular 
deformations through the complex fiber network.  
The above cited cellular deformations may be implicated in tissue driven 
mechanotransduction, i.e., translation of organ level mechanical stimuli into cellular responses. 
Indeed, the left heart side valve VICs (AV, MV) whose valve is under higher transvalvular 
pressure compared to the right side (PV, TV) are actually both stiffer, and they have a higher 
collagen biosynthesis (Hsp47) and a more active phenotype (SMA) (146). This finding 
implicates that VIC phenotypic response may shift due to changes in local stress, in cases such as 
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hypertension, mitral valve repair, or even calcification. In the case of mitral valve calcification 
the immediate substrate stiffness surrounding the VIC will be modified, and VIC phenotype is 
dependent on both substrate stiffness and age (168).  
The objective of this sub-aim was to quantitatively characterize the MV microstructure as 
a function of physiological loads, including localized 3D VIC deformations, and relate it to the 
fiber network. Physiologic biaxial loads were applied to the anterior mitral valve leaflet under a 
real time TPM system. In the following experiments, the collagen signal was acquired through 
SHG, the elastin signal was acquired from autoflourescence, and VIC deformations were 
acquired through a nuclear stain under controlled physiological loads, and quantified.  
2.2.2 Methods  
2.2.2.1 Tissue Preparation 
Hearts were acquired from 40 kg sheep at a local abattoir (MRG Food LLC). A 1 cm x 1 cm 
sample was taken from the anterior leaflet just below the annulus to above the first chordae 
tendineae attachment site (Figure 10a). The samples were split between two separate 
experiments: real-time deformations and imaging, and fixation and imaging. Four fiducial 
markers were placed in the center of the square and strains were measured optically by tracking 
this four marker array with Sony XCD-SX910 camera equipped with a Computar 55 mm 
telecentric lens interfaced with Labview Measurements and Automations. Samples were loaded 
into a miniature biaxial testing system: Two loops of 000 nylon suture of equal length were 
attached to each side of the specimens with four stainless steel hooks, which then connected to a 
dead weight on each side through a pulley system. Biaxial testing was conducted with the 
circumferential and radial specimen axes aligned with the device axes and submerged in a bath 
55 
of PBS at room temperature. Biaxial testing replicated the high levels of planar deformation 
experienced by the mitral valve leaflets in the belly region during coaptation (158, 169). 
 
Figure 10: Experimental setup. (A) Diagram of the ovine mitral valve (MV), where C and R 
represent circumferential and radial direction, respectively. (B) In the first experiment, samples were imaged 
under real-time deformations enface to 100 µm deep (grey) on both surfaces encompassing the atrialis (A), 
spongiosa (S), part of the fibrosa (F), and the ventricularis (V). (C) In the second experiment, samples were 
loaded to a tension level and fixed for two hours in 2% PFA. The respective strain profile for each sample 
was measured for both the (D) the first experiment and (E) the second experiment demonstrating a 
transversely isotropic response.  
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2.2.2.2 Experiment 1 – Real Time Deformations 
The first experiment objective was to quantitatively characterize the collagen and elastin fiber 
network as a function of controlled physiological loads. TPM is able to visualize collagen and 
elastin without probes that may modify the architecture, can encompass 3D volumes, and has 
deeper penetration depths than conventional laser scanning microscopy (LSCM). TPM has been 
used to qualitatively assess collagen and elastin fiber in the native semilunar valves, 
cryopreserved valves, and TEHV (170). However, these analyses were not quantitative. TPM has 
been quantitatively analyzed for both articular cartilage (171) and pericellular ECM (172). 
The miniature biaxial testing system was mounted underneath an Olympus FV1000 TPM 
system operated with Olympus fluoview software. The system was equipped with a Chameleon 
ultra diode-pumped laser, equipped with a 25x XL Plan N objective with a N.A. of 1.05 and a 
field of view of 500 µm. The excitation wavelength was chosen at 800 nm at a 7% laser intensity 
transmissivity. The emission wavelengths were received by two filters: The first channel was set 
to 400±100nm for SHG signal of collagen, and the second channel was set at 525±50 nm for 
elastin autofluorescence. The sampling speed was set to 2 μs/pixel with a 2 line kalman filter, 
and the scanning had an incremental z-step of 2 µm.  
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An equibiaxial tension path was chosen wherein the ratio of axial tension was 
maintained. The maximum tension level was set to 150 N/m, with a total of seven tension points 
chosen for the loading path with the majority focused on the initial nonlinear loading phase. A 
peak tension of 150 N/m was used because it corresponds to in vivo transvalvular pressure when 
the mitral valves are coapted during systole. The sample was first imaged enface to a maximum 
penetration depth of 100 μm from the atrialis surface at all seven tension levels, and then the 
process was repeated from the ventricularis surface. Enface imaging from the atrialis and 
ventricularis surface encompassed the spongiosa and fibrosa layer, respectively (Figure 10b). 
Hence, all the layers were encompassed with this technique.  
Using Matlab, image stacks were compiled into a maximum intensity z-projection 
(Figure 11a-b). The superimposed image stack was color channel separated to separate the 
collagen and elastin content. To quantify the fiber alignment from the z-projection a custom 
image analysis software was applied separately to the collagen and the elastin content. The 
image analysis software was written in Matlab by Courtney (173) using an algorithm developed 
by Chaudhuri (174), and modified by Karlon (175). This algorithm applies a variation of a Sobel 
operator to obtain the pixel intensity gradient to determine the preferred fiber direction for each 
sub-region (Figure 11c). The fiber direction from each sub-region was then placed into a 
histogram to determine the preferred fiber direction of the network. In addition, the fiber 
orientation index was found using the average over all fiber segments of cos2(θ) (COS OI), 
where θ represents the angle between a fiber segment and the direction of supposed alignment 
(176, 177). Statistical analysis compared the preferred fiber direction of the atrialis to the 
combined fibrosa and ventricularis using an independent-samples t-test at p<0.05 (PASW 
Statistics, V. 18). Values are reported as mean ± standard error. 
58 
 
Figure 11: Fiber network analysis. (A) Image stack obtained from TPM visualizing collagen (red) 
and elastin (green) fibers from SHG and autofluoresence, respectively. (B) The image stack was imported into 
Matlab and compiled into a single image from a maximum intensity z-projection. (C) The image was then 
color separated and the Karlon method algorithm was applied to track both collagen and elastin fiber. 
2.2.2.3 Experiment 2 – Fixation and Imaging 
The second experiment objective was to quantitatively characterize layer dependent VIC 
deformations under controlled physiological loads as a function of both collagen fiber 
straightening and alignment. Samples were loaded and fixed at one of the seven loads, with three 
samples fixed per load for a total of 21 samples. Samples were fixed for 2 hours in 2% 
paraformaldehyde at the desired tension level. Each sample was split into two sections (Figure 
10C).  
The first section was used for small angle light scattering (SALS) technique to represent 
the ECM fiber alignment over the entire area of the sample as a validation of the TPM technique, 
which focused on a considerably smaller region (178). The sample was glycerol dehydrated in 
graded solutions of glycerol and saline of 50%, 75%, 87%, and 100% for an hour each and then 
scanned with SALS. For each sample the resultant intensity distributions for all the spatial 
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locations was imported into Matlab. A smoothing function was applied to each intensity 
distribution, and then a dual Gaussian distribution was fit. From this fit the number of local 
maxima was determined as either one or two, and the resultant fiber direction of each peak was 
recorded and associated with its respective spatial location. 
The second section was paraffin embedded and cryosectioned along the circumferential-
transverse surface. One 7 µm section was taken for staining with Movats Pentachrome for 
thickness measurements. ECM composition and stratification were evaluated in circumferential-
transverse histological sections of adult porcine MV leaflets with a 10x and 25x objective 
(Figure 13a). Movat's pentachrome staining was used to visualize fibrous collagen (yellow), 
proteoglycan and GAGs (blue), and elastic fibers (black). In the MV leaflet, the collagen-rich 
fibrosa, proteoglycan-rich spongiosa, and elastin-rich atrialis and ventricularis layers were 
evident.  
Another 30 µm section was taken for nuclear staining and imaging on TPM: Slides were 
deparaffinized, permeabilized with Triton™ X-100 for 20 minutes, and stained with Sytox Green 
(Invitrogen) at a 1:250 concentration for 30 minutes. Slides were then gelvatol mounted and 
cover-slipped. Slides were then imaged under the TPM system at an excitation wavelength of 
830 nm with an incremental step of 1 µm. The first channel was set to 400±100nm for SHG 
signal of collagen, and the second channel was set at 525±50 nm for cytox green nuclear signal. 
In the second channel the elastin autoflouresence intensity was minimal compared to the cytox 
green intensity.  
Image stacks were imported into Imaris software for 3D nuclear deformation 
visualization and quantitative analysis (Figure 12). An automated surface was fitted to each 
nuclear point cloud, and erroneous detections were eliminated using an automated maximum 
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voxel threshold, and a minimum voxel threshold of 250. The eigenvectors associated with each 
surface, and the major and minor axes of an ellipsoid fit to each surface was imported into 
Matlab. The major and minor axes were converted into the nuclear aspect ratio, an indicator of 
cellular deformation, and the eigenvectors were converted into spherical coordinates to define 
theta and phi for the 3D orientation of the VIC. The user identified the four layers of the MV 
from a maximum intensity z-projection of the collagen network, and then the quantitative data 
for each nucleus was automatically associated with its respective layer. Statistical analysis of 
principal directions was determined with a one-way analysis of variance (ANOVA) with valve 
layers as the independent variable followed by a post-hoc Tukey’s test at p<0.05 (PASW 
Statistics, V. 18). Values are reported as mean ± standard error. 
Representative slices of the image stack were imported into ImageJ for further collagen 
structure analysis. Percent observable collagen crimp was found with the thresholding function 
for the fibrosa region (n=3 per tension level). Collagen fiber crimp period was also investigated. 
In the unloaded state, the collagen fibers were crimped with an identifiable period (Figure 14a). 
With application of load, the majority of the collagen fibers lost their crimp as they were 
mechanically engaged, although some residual crimp remained (Figure 14b). Collagen fiber 
crimp was quantified for the collagen fibers of the atrialis and fibrosa layer. Collagen crimp 
period was found by manually measuring ten different crimp periods per sample (n=3 per tension 
level). The crimp period for the fibrosa was determined from transverse sections as it 
encompassed the entire fibrosa layer, and for the atrialis layer crimp period was measured from 
enface real time imaging.  
61 
 
Figure 12: Cell deformation analysis. Image stack obtained from TPM were imported into Imaris 
software to visualize the Cytox Green stained cell nuclei in 3-D. Using built in image analysis functions in 
Imaris, 3-D surfaces were fit to all nuclei in the stack. Next, voxels were thresholded out by size to allow for 
more accurate nuclei surface fitting. Quantitative data was gathered including NAR and orientation angle. 
Finally, the data for each nucleus were associated with their respective MV layer with a custom Matlab 
algorithm. 
2.2.3 Results 
2.2.3.1 Mechanical Response 
Consistent with previously published results, the biaxial response of the MV was nonlinear, and 
transversely isotropic (158, 169). The circumferential and radial directions reached strains of 
20%, and 40%, respectively (Figure 10D). These strains from planar biaxial testing closely 
matched previously reported in-vitro analysis of the surface strains in the anterior leaflet of the 
functioning mitral valve apparatus (Refer to reference (169) Figure 5a). The MV followed a 
transition in the radial direction from a low modulus region to a high modulus region, while in 
the circumferential direction the valve had an immediate high modulus with minimal stretch. The 
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strain levels reached was similar to previously reported in-vivo analysis suggesting that biaxial 
equibiaxial tension protocol accurately approximated the strain field present during valve 
closure. More variation in the strain field for experiment 2 (Figure 10E) was seen compared to 
experiment 1 (Figure 10D) because comparisons were made between different animals with 
different thicknesses at each tension level for experiment 2, but the overall trend was found to be 
the same.  
2.2.3.2 Fiber Network Analysis 
The elastin-rich atrialis also contained collagen (Figure 13b-c), but the ventricularis layer was 
only a thin surface layer of elastin that transitioned to the collagen-rich fibrosa layer. The fibrosa 
layer was the thickest layer of the MV, while the ventricularis layer was the thinnest. From 
circumferential-transverse sections, the collagen (Figure 13b) and elastin (Figure 13a) in the 
atrialis was more punctate indicating an out-of-plane orientation in the radial direction, while the 
collagen in the fibrosa layer (Figure 13a-b) and elastin in the ventricularis (Figure 13a) was 
oriented perpendicular to the fibers in the atrialis layer along the circumferential direction. The 
perpendicular collagen and elastin orientation of the outer layers were further confirmed with 
enface TPM imaging of intact valves (Figure 13c). It was also found that the collagen and elastin 
in the atrialis layer were closely packed together (Figure 13c). This finding of a perpendicular 
fiber network was quantified with the application of a previously published automated algorithm 
(173) (Figure 13d).  
Confirmation of these two fiber networks on a larger scale was performed with SALS 
(178). Whereas TPM is isolated to a 500 µm area, SALS can cover an entire leaflet and is a 
composite of the entire volume. A custom Matlab algorithm first detected if two fiber 
populations exist. Two fiber populations may not be detected if they were very close together, or 
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if the thickness of the valve was beyond 500 µm in any area. The algorithm indicated that if two 
distinct fiber populations arose – one was oriented along the circumferential direction, and the 
other was oriented along the radial direction (Figure 13e). This corresponded with the collagen 
and elastin oriented radially in the atrialis, and the collagen and elastin oriented circumferentially 
in the fibrosa and ventricularis, respectively. 
The collagen fibers of the atrialis lost their crimp by about 10 N/m, while the collagen 
fibers of the fibrosa layer retained some residual crimp through 150 N/m (Figure 14c). This more 
immediate crimp removal for the collagen fibers in the atrialis layer corresponded with a smaller 
fiber diameter than those of the fibrosa layer, which were harder to define as distinct fibers 
compared to a sheet like structure (Figure 13c). Although residual crimp existed through 150 
N/m for the fibrosa layer, the majority of observable crimped collagen area was removed by 20 
N/m (Figure 14d). The removal of crimp at 20 N/m corresponded to when the biaxial mechanical 
response in the circumferential direction reached maximum strain. However, the removal of 
collagen crimp in the radial direction at 10 N/m did not correspond to when the biaxial 
mechanical response in the radial direction reached maximum strain.  
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Figure 13: The atrialis layer had a distinct population of fibers that were oriented perpendicular to 
the fibrosa and ventricularis layer. This finding was confirmed with multiple methodologies. (A) Histological 
assessment of ovine anterior MV leaflet stratification with Movat's pentachrome stain, where C and T 
represent circumferential and transverse direction, respectively. A, S, F, and V represent the atrialis, 
spongiosa, fibrosa, and ventricularis, respectively. (B) SHG image from a circumferential-transverse section. 
(C) SHG and autoflourescence from TPM of intact tissue imaged enface with collagen (red) and elastin 
(green). (D) Collagen and elastin preferred fiber direction were calculated. (E) Normalized orientation index 
(NOI) was calculated for the collagen and elastin fiber network as a function of tension and layer from SALS. 
Error bars represent standard error, and * indicates significance from atrialis at p<0.05. 
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Figure 14: Collagen fibers were visualized with SHG from TPM for transverse cryosections at both 
(A) 0 and (B) 150 N/m loads. (C) The collagen crimp period as a function of layer, (D) Observable fiber 
straightening area from percent total area. Error bars represent standard error. 
2.2.3.3 VIC Deformation Analysis 
The VICs in the fibrosa layer and ventricularis layer deformed significantly more than those of 
the atrialis and spongiosa layer, reaching a NAR of 3.3 (Figure 15a). The deviations for each 
layer were large indicating that per each layer there was a large amount of variation in the 
amount of VIC deformation. This corresponds well to the residual crimp that existed in some 
areas of the fibrosa layer at maximum load: Some VICs were compacted by straightened 
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collagen fibers while other fibers still had residual crimp, and thus, were not deforming VICs to 
the same magnitude. The VICs also had an intrinsic ellipsoidal configuration at the free float 
state having a NAR of 2.5.  
In addition to VIC deformation, the 3D orientation of each VIC was determined. By 
comparing the orientation of the VICs in each layer as a function of tension it was clear that a 
reorientation occurred as a function of layer. At the free float configuration the VICs were not 
well oriented with high standard errors. At maximum physiological tension, the VICs of the 
fibrosa and ventricularis oriented towards the circumferential direction while the VICs of the 
atrialis and spongiosa oriented towards the radial direction. Note that the VIC populations were 
oriented along the preferred fiber direction of their respective layers. Although the spongiosa 
VICs were orienting towards the radial direction, they showed a larger standard error compared 
to the VICs of the atrialis layer that had an aligned fiber network (Figure 15d). With tension, 
there was also a reorientation of the VIC populations in the circumferential-radial plane, or in-
plane deformation, except for the atrialis layer (Figure 15e). This corresponded to the direction 
of collagen sheet orientation for the atrialis and fibrosa layer. 
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Figure 15: (A) MV nuclear aspect ratio (NAR) with respect to tension for each of the valves layers. A, 
F, S, V represent the atrialis, fibrosa, spongiosa, and ventricularis, respectively. (B) 3D nuclear geometries 
were acquired and principal axes directions (e1, e2, e3) were found. (C) The major principal axis (e1) was 
defined in spherical coordinates from angles θ and Ф. (D) The orientation angle of VIC nuclei off of the 
circumferential axis (θ) was compared as a function of layer and tension. (E) The in-plane orientation angle of 
VIC nuclei (Ф) was compared as a function of valve layer and tension. Error bars represent standard error, 
and * indicates significance at p<0.05. 
2.2.4 Discussion  
For the first time, the MV collagen and elastin fiber kinematics in addition to VIC deformation 
was quantified under controlled biaxial loading which replicated physiologic strain levels (157, 
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169). The study of MV layer-dependent fiber architecture and kinematics is critical to 
understanding the complexity of the native heart ECM. It is clear that the MV cell-fiber 
kinematics are complex as seen with mitral valve surgical repair whereby remodeling is initiated 
due to changes in leaflet stress distribution and resultant closure mechanics. This sub-aim 
provides an in-depth quantitative assessment of VIC deformation and associated ECM fiber 
network micromechanics.  
2.2.4.1 Two Opposing Fiber Networks 
This sub-aim found subtle layer differences in collagen and elastin fiber planar organization. 
Surprisingly, two opposing collagen and elastin networks exist on the opposite sides of the mitral 
valve leaflet. This structure is not seen in the AV. The AV collagen is circumferentially oriented 
and mainly exists in the fibrosa layer, and the elastin is oriented radially and existed in the 
ventricularis layer. Why does the MV have two separate opposing networks compared to the 
semilunar valve architecture? The MV is under the highest TVP gradient and may need a 
secondary fiber network in the atrialis to provide further support during the loading cycle. 
However, this could be simply achieved with an increase in thickness or a single randomly 
oriented network. Instead, there exist two fiber networks on opposite sides of the valve that are 
perpendicular to each other. The existence of opposing fiber networks in the mitral valve is 
similar to that of the alternating collagen fiber bundles in the heart (94).  
For both the AV and MV the bulk collagen fibers are in the fibrosa oriented in the 
circumferential direction resulting in minimal strain along this axis. However, there is a large 
radial deformation in the AV, and the secondary network of the MV in the atrialis is oriented 
along the radial direction. Hence, the radially oriented collagen in the MV atrialis layer may 
serve to decrease compliance along this axis with strains only reaching 40% compared to the AV 
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reaching 60%. Also, the radially oriented elastin in the atrialis may further aid in returning the 
valve to its initial configuration, as seen for the AV in the ventricularis (179, 180). The 
distribution of two separate networks may also allow for greater controllability over two axes of 
flexure to further optimize the gross 3-dimensional leaflet deformations during the closure 
mechanics of the valve.  
Another question that arises is how did these two distinct networks form? The elastin is 
oriented radially along the blood ejecting surfaces for both the MV (atrialis surface) and AV 
(ventricularis surface), whereas the elastin is oriented circumferentially for the ventricularis 
surface of the MV. Thus, flow may be a potential mechanism in either the formation or the 
orientation of elastin. Specifically, endothelial cells are known to be sensitive to the 
directionality of flow in-vitro (181). Although VICs are not in contact with blood, evidence 
indicates that valvular endothelial cells regulate the phenotype of VICs (182). Hence, endothelial 
cells may play a critical role in the regulation of the directional formation of elastin. 
2.2.4.2 Layer Dependent VIC-Collagen Micromechanical Coupling 
The ECM is a dynamic environment with proteins being continuously degraded and replaced. 
Perturbations to this system have been shown to be caused with age and disease. In order to gain 
a better understanding of MV remodeling it is necessary to gain a better understanding of VIC 
mechanobiology, ie. how VICs’ biosynthetic activity is impacted by organ level loads. There is a 
lack of understanding of how local forces are transduced to VICs from organ level loads. In this 
sub-aim, MVICs experienced layer specific deformations with load, as reported for the semilunar 
valves (133). VICs in the fibrosa layer underwent the largest deformation compared to those in 
the other layers. As previously concluded in the first section of Specific Aim 1 (183), 
deformation of VICs is largest in the fibrosa layer because they are compacted by straightened 
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collagen fibers. We found that VICs in the atrialis orient more toward the radial direction in 
parallel to the collagen fibers in that layer, while VICs in the fibrosa orient towards the 
circumferential direction in parallel to the collagen fibers in that layer. Although collagen fibers 
exist in the atrialis layer they are thinner, more fibrous, and have more spacing compared to the 
collagen fibers in the fibrosa layer that display a sheet organization. This additional spacing 
between the collagen fibers in the atrialis results in less compaction corresponding to a lower 
deformation level than seen in fibrosa layer VICs. This finding confirms that VIC deformation is 
closely coupled to collagen fiber orientation, being compacted and extending between the spaces 
of the collagen fibers.  
2.2.4.3 Summary and Implications 
These subtle layer differences in ECM planar organization and the intricate interrelationship 
between ECM planar organization and VIC deformation indicate the promising potential of 
anatomically site-specific ECM scaffolds. Compared to the inherent limitations of synthetic 
platforms to engineer a three dimensional biomaterial that mimic the complexities at the 
microstructural level for heart repair or replacement, ECM scaffolds are derived from tissues and 
may retain the complexity of the native ECM fiber network. However, the manufacturing 
process to produce an ECM scaffold from native tissue requires the usage of many chemicals 
including detergents. Detergents such as SDS are known to result in denaturation of collagen 
fibers but are used in the majority of decellularization protocols, especially creating cardiac ECM 
scaffolds. The questions arise both whether this decellularization indeed damages the complex 
composition and structure of the native heart ECM, and whether any damage to the biochemical 
and/or structural properties of the ECM impacts this complex cell-ECM interaction. 
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3.0  COMPOSITION, STRUCTURE AND MECHANICS OF DETERGENT 
TREATED TISSUE2 
3.1 INTRODUCTION 
Specific Aim 1 established that the native heart is extremely complex with site-specific cellular 
gene expression, fiber network organization, and cell-ECM coupling. Site-specific ECM 
scaffolds may retain this anatomically specific composition and three-dimensional fiber network 
organization. However, the manufacturing of ECM scaffolds is a complex process that requires 
balance between achieving successful decellularization to prevent an adverse immune response 
and minimizing damage to the composition, biologic activity, and mechanical integrity of the 
ECM (61).  
                                                 
2This work has been adapted from the following published manuscript:  
Faulk DM, Carruthers CA, Warner HJ, Kramer CR, Reing JE, Zhang L, D’Amore A, Badylak SF. The 
effect of detergents on the basement membrane complex of a biologic scaffold material. Acta Biomaterialia. 2013; 
Doi: 10.1016/j.actbio.2013.09.006. 
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3.1.1 Criteria for Successful Decellularization and Relationship to Host Response 
A stringent set of criteria for successful decellularization were developed based upon previous 
findings (100, 184). These criteria are defined as follows: 
1. No visible nuclear material by histological examination with H&E and DAPI stain 
2. DNA content of less than 50 ng/mg day weight 
3. No remnant DNA with base pair length greater than 200 
The focus upon DNA is justified because it directly correlates with adverse host reactions 
(105). For example, poor cytocompatibility was found upon reintroduction of cellular tissue, 
even autologous, in a rodent partial thickness abdominal wall defect. This poor cytocompatibility 
was characterized by the deposition of dense connective scar tissue and a predominantly M1 
macrophage phenotype. In contrast, properly prepared acellular ECM scaffolds elicited a 
constructive remodeling response with the formation of site specific functional tissue and a 
predominantly M2 macrophage phenotype (104). Another study found that more aggressive 
decellularization of SIS was associated with a shift in macrophage phenotype from M1 to M2 in-
vitro, with notable differences found in-vivo in a rodent model in the distribution of M1 versus 
M2 macrophages (105). Thus, if the aforementioned decellularization criteria are not reached 
such that residual cellular material is still present within the ECM, an adverse host response may 
result. 
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3.1.2 Adverse Effects of the Manufacturing Process 
Successful decellularization is only one contributing factor toward preventing an adverse host 
response to an ECM scaffold. Both the chemicals and methods of terminal sterilization used in 
the manufacturing process are known to effect an ECM scaffold’s composition, ultra-structure, 
and the subsequent host response. For example, while SIS in a rodent model elicited a 
predominantly M2 macrophage phenotype and constructive remodeling at 16 weeks, a cross-
linked SIS had chronic inflammation. Chemical crosslinking has been correlated with delayed 
degradation (185), a chronic mononuclear cell accumulation around the device (43, 185), and 
scar tissue formation (43, 44, 185).  
The method of terminal sterilization affects the structural and mechanical properties of an 
ECM scaffold. It was found that UBM sterilized with gamma (2.0 Mrads) and electron-beam 
(2.2 Mrads) radiation had a decrease in uniaxial and biaxial strength, maximum tangential 
stiffness, and energy dissipation while UBM treated with ETO (750 mg/hr for 16 hr) had the 
least detrimental effect (186). The method of sterilization also correlated with distinct differences 
in the host response (43).  
While the described studies have mechanistically investigated the effect of remnant 
cellular content, cross-linking, and terminal sterilization on the ECM scaffold’s composition, 
structure, and cytocompatibility there is a lack of understanding on how different detergents in 
the manufacturing process impact these parameters. Detergents are used in the manufacturing 
process to both solubilize cell membranes and dissociate DNA from proteins. Several methods 
for generating ECM scaffolds have been published, each of which describes a unique and 
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specific recipe of enzymes and detergents. Table 4 lists three protocols for whole organ 
decellularization of the heart and one protocol for decellularization of myocardium sheets. 
Table 5 lists additional protocols that have been reported for other organs and tissues. As 
seen in Table 4’s and Table 5’s list of commonly used manufacturing protocols, there is clearly a 
large degree of variability in detergent type, incubation time, and concentration in the literature. 
Most of the manufacturing protocols contain multiple steps with more than one detergent. The 
detergents used range from non-ionic detergents such as Triton™ X-100 to ionic detergents such 
as SDS.  
The majority of heart decellularization protocols contain a step that uses SDS for at least 
12 hours (Table 4), and an SDS step is also prevalent for decellularization of other organs and 
tissues (Table 5). While ionic detergents such as SDS can be more effective for removal of 
cellular material than non-ionic and zwitterionic detergents (187), studies have shown that 
subjecting tissues to harsher detergents such as SDS can disrupt the ECM structure (188), 
eliminate growth factors (106), and denature essential proteins (114-116, 189). While there has 
been some comparison of multiple step protocols used to achieve decellularization (72, 103, 106-
113) none have comprehensively isolated and compared individual detergents’ effect on scaffold 
composition, structure, or mechanics. The hypothesis of this aim is that ionic detergents such as 
SDS will result in a loss of ECM constituents and a decrease in mechanical strength that is 
correlated at the micro-structural scale. 
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Table 4: Protocols for heart decellularization. 
Whole Organ Decellularization Tissue Decellularization 
Porcine Heart
 
(71, 190) 
Porcine & Rat Heart 
(72, 113, 191) 
Rat Heart 
(113) 
Porcine Myocardium Sheets 
(60) 
0.02% Trypsin  
(3 hr) 
1% SDS  
(12 hr) 
1% SDS 
(12 hr) 
1% SDS  
(60-120 hrs) 
3% Triton™ X-100  
(2.5 hr) 
1% Triton™ X-100 
(0.5 hr) 
20% glycerol  
(12 hr) 
1% Triton™ X-100  
(0.5 hr) 
4% Sodium deoxycholate  
(3 hr) 
1x PBS  
(124 hr) 
1% Saponin 
(12 hr) 
Type I water  
(12-24 hrs) 
0.1% Peracetic acid  
(1.5 hr) 
 
20% glycerol 
(12 hr) 
 
Type I water & 
2x PBS rinses  
(0.5 hr) 
 
200 UI/ml Dnase I  
(12 hr) 
  
Table 5: Protocols for liver, kidney, lungs, bladder, and cornea decellularization. 
Whole Organ Decellularization Tissue Decellularization 
Rat Liver 
(58) 
Rat Liver 
(64) 
Rat Kidney 
(192) 
Rat Lungs 
(67) 
Porcine Bladder 
(102) 
Cornea 
(193) 
0.02% Trypsin  
(2 hr) 
0.1% SDS 
(72 hr) 
3% Triton™ X-100 
 
CHAPS  
(3 hrs) 
Mechanical  
Separation 
0.3% SDS  
(20 hr) 
3% Triton™ X-100  
(24 hr)   
Dnase 
 
 
PAA  
(2 hrs) 
Dnase 1  
(3 hr) 
0.1% PAA  
(1 hr)   
4% SDS 
   
 
  
Type I water 
2x PBS rinses  
(0.5 hr)       
 
  
3.2 METHODS 
3.2.1 Tissue Source 
Two source tissues were chosen for their relevance in application to cardiac repair: Urinary 
bladder and heart. Urinary bladder was chosen as a source material because it has been used to 
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create a clinically relevant material for cardiac repair known as UBM (88, 89). Further, urinary 
bladder supports an epithelial cell layer upon a BMC, and is commonly decellularized as a sheet 
with detergent immersion and mechanical agitation. Porcine urinary bladders were obtained from 
animals at a local abattoir (Thoma's Meat Market, PA). Bladders were frozen (>16 hr at −80 °C) 
and thawed completely before use. The BMC and underlying lamina propria were mechanically 
isolated and harvested from the bladders as previously described (102, 186, 194). The term 
“detergent treated bladder” will refer to detergent treatment of the isolated BMC and underlying 
lamina propria of the urinary bladder.  
Heart tissue was chosen because it is a site-specific ECM scaffold that has been used for 
cardiac repair (66, 87). Further, heart tissue supports an endothelial layer and is effectively 
decellularized through whole organ retrograde detergent perfusion (Figure 16). Porcine hearts 
were obtained under controlled conditions to minimize damage to the vasculature near the 
surface (Tissue Source, Indiana). Hearts were frozen (>16 hr at −80 °C) and thawed completely 
before use. For subsequent analysis after decellularization the right ventricle free wall was used 
because of its previous usage as a cardiac patch (87). 
 
Figure 16: Whole organ heart decellularization by retrograde perfusion with a peristaltic pump. 
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3.2.2 Decellularization Protocol 
Tissues were subjected to one of four commonly used detergents (From Table 4 and Table 5):  
1. A non-ionic detergent called Triton™ X-100 
2. A zwitterionic detergent called 3-[(3-cholamidopropyl)dimethylammonio]-1-
propanesulfonate (CHAPS) 
3. An ionic detergent called sodium deoxycholate 
4. An ionic detergent called sodium dodecyl sulfate (SDS) 
Thus, the detergent selection represents the three categories of detergents (non-ionic, 
zwitterionic, and ionic detergents), and also accounts for the different molecular sizes and 
structure of two ionic detergents (sodium deoxycholate, and SDS). The concentration for 
decellularization of bladder and heart was chosen to both replicate those used in the literature 
while maintaining similar molarities (Table 6). The majority of the detergents were above the 
critical micelle concentration (CMC) to effectively form micelles for removal of cellular 
components. CHAPS was the only detergent used at its CMC, and was only used for treatment of 
the bladder due to both cost constraints and its usage in the literature for only decellularization of 
a sheet such as the cornea.  
The bladder was treated with these detergents through mechanical agitation at 3000 RPM 
(102, 186, 194), while the heart was treated with these detergents through retrograde perfusion 
(65, 71, 190). During the whole organ heart decellularization process the speed of the peristaltic 
pump was incrementally increased from 400 ml/min to 2.2 L/min following a previously 
reported protocol (190). The speed was incrementally increased to account for the decrease in 
heart resistance with decellularization in an attempt to estimate a pressure control system.  
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A protocol was formulated to subject both the bladder and the heart to these commonly 
used detergents under controlled conditions with all other variables constant (Table 7). Heart 
tissue was treated for 12 hours because this is the most commonly used duration for heart 
decellularization (Table 4). Porcine bladders were treated for double this period at 24 hours to 
mimic some of the longer decellularization protocols in the literature (Table 5). For both tissues a 
commonly used step of treatment with trypsin was included to detach cells from the tissue. 
Additionally, between each step a rinse of hypertonic and hypotonic solution was used to lyse 
cells. After the tissue was subjected to a detergent a prolonged rinse was completed to remove 
residual detergent. Because whole organs are more difficult to decellularize many reported 
protocols use multiple detergents. Therefore, an established multiple step protocol from the 
literature (71, 190) was also included to investigate serial detergent usage for heart 
decellularization. A control was included for both the bladder and heart tissue. For the bladder 
the control was defined as treatment with 0.02% trypsin, and 0.05% EDTA for 2 hours. For the 
heart the control was defined as the native tissue. The goal of detergent treatment was not 
necessarily to reach the criteria for successful decellularization, but to compare the effect of 
detergent treatments on the source tissue under similar controlled conditions. Detergent treated 
tissues were either fixed in 10% neutral buffered formalin, 2.5% gluteraldehyde, or frozen in 
liquid nitrogen for subsequent analysis. 
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Table 6: Concentration of selected detergent solutions 
 
Percent Solution 
(%) 
Molarity 
 (mM) 
Critical Micelle 
 Concentration (mM) 
Molecular Weight 
 (g/mol) 
Triton™ X-100 3.0 48 0.5 625 
CHAPS 0.5 8 8 615 
Sodium deoxycholate 
2.0 (heart)  
4.0% (bladder) 
49 
72 4 415 
SDS 1.0 35 9 288 
 
Table 7: Decellularization protocols 
Bladder Protocol 
 
Heart Protocol 
 
Heart Multiple Step Protocol 
(71, 190) 
0.02% Trypsin, 0.05% EDTA 
at 37 °C (2 hrs) 
0.02% Trypsin, 0.05% EDTA at 
37 °C (2 hrs) 
0.02% Trypsin, 0.05% EDTA at 
37 °C (3 hr) 
2x PBS, Type I water (0.25 
hr, 2x) 
2x PBS, Type I water (0.25 hr, 
2x) 
2x PBS, Type I water (0.25 hr, 
2x) 
Detergent (24 hrs) Detergent (12 hrs) 3% Triton™ X-100 (2.5 hr) 
1x PBS, type I water rinse 
(0.25 hr, 2x) 
1x PBS, type I water rinse 
(0.25 hr, 2x) 
2x PBS, Type I water (0.25 hr, 
2x) 
1x PBS rinse (24 hrs) 
 
1x PBS rinse (24 hrs) 
 
4% Sodium deoxycholate (3 
hr) 
  
2x PBS, Type I water (0.25 hr, 
2x) 
  
0.1% Peracetic acid (1.5 hr) 
 
  
1x PBS rinse and type I water 
rinses (0.25 hr, 2x) 
 
3.2.3 Double Stranded DNA Quantification 
ECM Scaffolds were digested in 0.6% Proteinase K solution for at least 24 hours at 50°C until 
no visible tissue remained. Phenol/Chloroform/Isoamyl alcohol was added and samples were 
centrifuged at 10,000xg for 10 min at 4°C. The top aqueous phase containing the DNA was 
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transferred into a new tube. Sodium acetate and ethanol was added to each sample and the 
solution was mixed and placed at -80°C overnight. While still frozen, the samples were 
centrifuged at 4°C for 10 min at 10,000xg. Supernatant was discarded and all residual alcohol 
was removed. Pellet was suspended in TE buffer. Double stranded DNA (dsDNA) was 
quantified using Quant-iT PicoGreen Reagent (Invitrogen Corp., Carlsbad, CA, USA) according 
to the manufacturer’s instructions in duplicates. Samples were normalized to dry weight of the 
ECM scaffold. The dry weight is defined as the material after decellularization and lyophilization 
that was used in the initial proteinase k solution digestion.  
3.2.4 Soluble Collagen and Sulfated GAG Quantification  
10 mg ECM/ml (dry weight) were enzymatically digested in a solution of 1 mg/ml porcine 
pepsin (Sigma Aldrich, St. Louis, MO) in 0.01 N HCl under a constant stir rate for 72 h at room 
temperature. The pH neutralized pepsin digests were diluted and assayed for soluble, triple 
helical collagen content using the Sircol Collagen Assay (Biocolor Ltd., Carrickfergus, United 
Kingdom) per the manufacturer’s instructions. The pH neutralized pepsin digest were also 
analyzed for total protein recovered using the BCA protein assay (Pierce). A pepsin buffer 
solution was used as the negative control and subtracted from the signal. Similarly, 50 mg/ml of 
powdered ECM in 100 mM Tris (pH 7.5) was digested with 0.1 mg/ml proteinase K (Sigma) at 
50 ºC for 24 h with gentle agitation. The proteinase K digests were then assayed for sulfated 
GAG concentration using the Blyscan Sulfated Glycosaminoglycan Assay (Biocolor Ltd.) per 
the manufacturer’s instructions. All results were normalized to dry weight tissue. Assays were 
performed in duplicate on three independent samples for each treatment group.  
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3.2.5 Growth Factor Assays 
Three hundred (300) mg of detergent treated urinary bladder powder was suspended in 4.5 ml of 
urea-heparin extraction buffer. The extraction buffer consisted of 2 M urea and 5 mg/ml heparin 
in 50 mM Tris with protease inhibitors [1mM Phenylmethylsulfonyl Fluoride (PMSF), 5 mM 
Benzamidine, and 10 mM N-Ethylmaleimide (NEM)] at pH 7.4. The extraction mixture was 
rocked at 4oC for 24 hours then centrifuged at 3,000 g for 30 minutes at 4oC. Supernatants were 
collected, and 4.5 ml of freshly prepared urea-heparin extraction buffer was added to each pellet. 
Pellets with extraction buffer were again rocked at 4oC for 24 hours, centrifuged at 3,000 g for 
30 minutes at 4oC, and supernatants were collected. Supernatants from first and second 
extractions were dialyzed against Barnstead filtered water (three changes, 80 to 100 volumes per 
change) in Slide-A-Lyzer Dialysis Cassettes, 3500 MWCO (Pierce, Rockford, IL). The 
concentration of total protein in each dialyzed extract was determined by the bicinchoninic acid 
(BCA) Protein Assay (Pierce, Rockford, IL) following the manufacturer’s protocol, and extracts 
were frozen in aliquots until time of assay.  
Concentrations of basic fibroblast growth factor (bFGF),and vascular endothelial growth 
factor (VEGF) in urea-heparin extracts of detergent treated urinary bladder samples were 
determined with the Quantikine Human FGF basic Immunoassay (R&D Systems, Minneapolis, 
MN), and the Quantikine Human VEGF Immunoassay (R&D Systems). Manufacturer’s 
instructions were followed for both growth factor assays. Each assay for bFGF and VEGF was 
performed in duplicate, and each growth factor assay was performed two times. It should be 
noted that growth factor assays measured the concentration of each growth factor and did not 
measure growth factor activity.  
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3.2.6 Histologic Staining and Immunolabeling of the Detergent Treated Tissue 
The BMC is one of the first ECM structures made by the developing embryo with its major 
constituent laminin-111, synthesized at the eight cell stage (195). This BMC is the first ECM 
structure with which embryonic stem cells interact and represents a key biosignal for separating 
endoderm from ectoderm; thus, it is logical that the BMC can represent an important structure in 
an ECM scaffold. ECM Scaffolds containing a BMC are used in a variety of pre-clinical and 
clinical applications (88, 118, 196-203), and some of these ECM scaffolds are seeded with cells 
before use (204-206). The UBM, originating from urinary bladder, is an example of an ECM 
scaffold that contains a BMC structure. Thus, the treated bladders were immunolabeled for ECM 
constituents that are known to be present in the BMC (200).  
Fixed detergent treated bladders were embedded in paraffin and cut into 5µm sections. 
Sections were either stained with Hematoxylin and Eosin (H&E), Movat’s Pentachrome, or used 
for immunolabeling. For immunolabeling, slides were manually deparaffinized, placed in Citrate 
Antigen Retrieval Buffer (10 mM, pH 6), and heated to 95°C for 20 min. Slides were then cooled 
to room temperature, rinsed in 1X PBS three times for 3 min, placed in humidity chamber to 
incubate for 1 hr with blocking solution (2% Goat Serum, 1% BSA 0.1% Triton™ X-100 0.1% 
Tween) at room temperature, then incubated overnight at 4°C with anti-collagen I antibody 
(Sigma-Aldrich, C2456, 1:1000) in blocking solution. Slides were then rinsed with 1X PBS as 
above, treated with 30% hydrogen peroxide in methanol solution for 30 min, and re-rinsed. 
Biotinylated secondary antibody Horse Anti-Mouse IgG (Vector Labs, 1:100) was then applied 
for 30 min. Slides were rinsed as above, ABC solution applied for 30 min in humidity chamber 
at 37°C, re-rinsed, and 3,3'-diaminobenzidine (DAB, Vector Labs) was applied under 
microscope.  
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To stain collagen IV (ab6586, Abcam, 1:500), laminin (L9393, Sigma-Aldrich, 1:100), 
and Collagen VII (C6805, Sigma-Aldrich, 1:10) staining was conducted using the same protocol 
as collagen I with an added 0.05% pepsin in 0.01 mM hydrochloric acid for 15 minutes in 
humidity chamber at 37°C following citrate acid buffer antigen retrieval. Collagen VII 
additionally used a blocking solution that contained a higher concentration of goat serum (4%) 
and BSA (2%), and a 1 hour hydrogen peroxide incubation time. After DAB staining, all slides 
were counterstained with hematoxylin, dehydrated and manually coverslipped using standard 
mounting medium. Images were taken at the luminal interface of the tissue. 
3.2.7 Analysis of the ECM Fiber Network 
Scanning electron micrographs (SEM) was used to examine the surface topology of bladders and 
hearts treated with each detergent. Samples were fixed in 2.5% glutaraldehyde in 1X PBS, cut 
into blocks of approximately 8mm3, and washed thoroughly in 1X PBS for three times at 15 
minutes each. Samples were then fixed in 1% OsO4 in 1X PBS for 15 minutes each, dehydrated 
in graded series of alcohol (30%-100%) baths for 15 minutes each. Samples were then critically 
point dried with Hexamethyldisiloxane mounted on studs, sputter coated, and stored in a 
desiccator until imaged. SEM images of the luminal surface were captured using a JEOL 6335F 
Field Emission SEM with backscatter detector. 
A complete set of fiber network descriptors was collected from SEM images including: 
pore size distribution, node density (number of fibers intersections per µm2), and fiber diameter. 
Porosity was described by the mean of the pore size (µm2) histogram. Automated extraction of 
these fiber architectural features was achieved with an algorithm, which has been previously 
described in detail (207). Briefly, the SEM image is digitally processed by a cascade of steps 
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including equalization with a 3x3 median filter, local thresholding through the Otsu method, 
thinning, smoothing, morphological operators, skeletonization, binary filtering for Delaunay 
network refinement, and ultimately the detection of fiber network architecture and its descriptors. 
Per each treatment 8 images were processed. 
3.2.8 Quantification of Collagen Fiber Denaturation via SHG 
To both visualize and quantify the integrity of the collagen fiber network of the detergent treated 
tissue, intact samples were imaged enface from the luminal surface of the detergent treated tissue 
with an Olympus FV1000 TPM. The Olympus FV1000 TPM system was operated with Olympus 
fluoview software, and was equipped with a Chameleon ultra diode-pumped laser, and a 25x XL 
Plan N objective with a N.A. of 1.05 and a field of view of 500 µm. The excitation wavelength 
was chosen at 800 nm at a 5% laser transmissivity. The photomultiplier voltage was maintained 
at 400 V across all samples for subsequent signal intensity analysis. The emission wavelength 
was received by a filter set to 400±100nm for second harmonic generation signal of collagen. 
Image scans were performed at depths of 25 µm, 50 µm, 75 µm, and 100 µm with a sampling 
speed set to 2 μs/pixel with a 2 line Kalman filter. 
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Image sections were then imported into ImageJ for intensity analysis. A threshold 
background subtraction was applied, and then the integrated density function whereby 
area*intensity. Per each treatment 3 images were processed. This parameter provides a relative 
measurement of the SHG signal. It has previously been found that denaturation of collagen fibers 
results in the destruction of the SHG due to the loss of the noncentrosymmetric crystalline 
structure at the molecular level (208). Additional image stacks were acquired for select samples 
with an incremental z-step of 0.5 µm to a depth of 100 µm for 3D reconstruction and 
visualization using Imaris software. 
3.2.9 Mechanical Assessment 
A MTS Insight Electromechanical 2 kN standard length (MTS Co., Eden Prairie, MN) tensile 
test machine was used with a ball-burst compression cage to measure the passive biaxial strength 
of the detergent treated heart tissue. A load cell was used. The ball-burst cage and the MTS 
machine were used according to the Standard Test Method for Bursting Strength of Knitted 
Goods, Constant-Rate-of-Traverse (CRT) Ball- burst Test (ASTM D 3787-07). A 25.4mm 
polished steel ball was advanced at a constant rate (25.4mm/min) through the sample (102). The 
ring clamp has an internal diameter of 44.5 mm. The ball-burst strength is defined as the force 
that is required to burst the sample when applied perpendicular to the plane of the sample. The 
stiffness is defined as the derivative of the force versus displacement curve. Experiments were 
performed on three separate detergent treated hearts per group on the right ventricular free wall. 
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3.2.10 Statistical Analysis 
A one-way ANOVA was completed for each data set, where the independent variable was 
detergent treatment, with significance at p<0.05. if significance was found, either a post-hoc 
Dunnett’s test or Tukey’s test was completed to determine the specific differences between 
detergent treatment groups with significance at p<0.05. Graphs show mean ± standard error 
unless otherwise specified. 
3.3 RESULTS 
3.3.1 Urinary Bladder Analysis 
3.3.1.1 dsDNA Content 
No visible nuclei were observed by imaging of Hematoxylin and Eosin stained sections (Figure 
17). dsDNA quantification of detergent treated bladders showed significant removal compared to 
the control. Bladders treated with SDS contained significantly less dsDNA than those treated 
with CHAPS, or sodium deoxycholate. SDS was the only detergent able to meet a previously 
established decellularization criterion of 50 ng dsDNA/mg tissue (209). 
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Figure 17: Decellularization assessment of the detergent treated bladder with (A) H&E to identify 
cellular content, and (B) Picogreen assay to quantify dsDNA. Scale bar represents 200 µm. Graph shows 
mean ± standard error, and * indicates significance from control at p<0.05. 
3.3.1.2 Collagen, Sulfated GAG,  and Growth Factor Content 
While bladders treated with Triton™ X-100, CHAPS, and sodium deoxycholate retained a level 
of soluble collagen similar to that of the control, treatment with SDS resulted in a significant loss 
of detectable soluble collagen (Figure 18). While this assay only detected soluble collagen such 
that higher levels of non-soluble remnant collagen may still exist, this finding indicated that 
detergent treatment with SDS resulted in either a decrease in soluble collagen present or 
modification of the molecular structure to the point of insolubility.  The higher level of soluble 
collagen for Triton X-100 compared to the water control is an artifact of the normalization to dry 
weight. More specifically, the relative density of ECM to total weight is increased after 
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decellularization for Triton X-100 because of the removal of cellular content compared to the 
control. Bladders treated with Triton™ X-100 retained GAGs similar to that of the control, while 
bladders treated with sodium deoxycholate and SDS retained no detectable GAGs. CHAPS 
retained a lesser amount of detectable GAGs than the control. The majority of the detergent 
treated bladders retained less VEGF and bFGF than the control (Figure 19), but there was almost 
no detectable VEGF for bladders treated with sodium deoxycholate and SDS.  
 
Figure 18: Biochemical assay of the detergent treated bladder to quantify soluble (A) protein, (B) 
collagen, and (C) GAGs. Graph shows mean ± standard error, and * indicates significance from control at 
p<0.05. 
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Figure 19: Biochemical assays to quantify soluble (A) protein, (B) VEGF, and (C) bFGF normalized 
to dry weight tissue. Graph shows mean ± standard error. 
3.3.1.3 Immunolabeling  
The control showed positive staining at the BMC surface of collagen I, collagen IV, collagen 
VII, and laminin as previously reported (Figure 20) (200). All bladders treatments were positive 
for collagen I staining. No detergent treated bladders stained positive for collagen VII, or 
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laminin. While bladders treated with CHAPS and SDS did not stain positive for collagen IV, 
bladders treated with Triton™ X-100 and sodium deoxycholate had positive expression of 
collagen IV. However, this positive staining was not localized to the surface as would be 
expected for an intact BMC. 
 
Figure 20: Immunolabeling of proteins associated with the BMC for detergent treated bladder to 
assess BMC integrity. Scale bar represents 100 µm. 
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3.3.1.4 Movats Stain 
Bladders treated with Triton™ X-100 and sodium deoxycholate retained elastin fibers, whereas 
CHAPS had no visible elastin fibers and SDS had only a small portion of thin fragmented fibers 
(Figure 21). GAGs were visible in both bladders treated with Triton™ X-100 and CHAPS while 
not visible for bladders treated with sodium deoxycholate and SDS. This observation was 
consistent with the sulfated GAG measurement (Figure 18).  
 
Figure 21: Movats Pentachrome of the detergent treated bladder where yellow, blue, and purple 
represents collagen, proteoglycans and GAGs, and elastin, respectively. Scale bar represents 100 µm. 
3.3.1.5 Analysis of the Fiber Network 
SEM of the luminal surface of bladders showed qualitatively that treatment without a detergent, 
with Triton™ X-100, or with sodium deoxycholate retained an intricate fiber network (Figure 
22A). However, treatment with CHAPS and SDS resulted in an amorphous structure lacking 
distinct fibers. The fiber diameter was not different for bladders treated with Triton™ X-100 or 
sodium deoxycholate compared to the control (Figure 22B). While there was a slightly smaller 
pore size for bladders treated with Triton™ X-100 and sodium deoxycholate compared to the 
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control, and a higher node density for bladders treated with Triton™ X-100 these changes were 
small compared to previously published variations (207, 210). Thus, bladders treated with 
Triton™ X-100 and sodium deoxycholate were able to retain the fiber network original 
configuration. TPM imaging confirmed a loss of a distinct fiber network for bladders treated 
with SDS compared to Triton™ X-100 (Figure 23). The lower collagen signal intensity for 
bladders treated with SDS indicates fiber denaturation. The higher signal intensity value for 
Triton™ X-100 and sodium deoxycholate compared to the water control may be due an increase 
in the density of ECM constituents from a loss of cellular material. The signal intensity values 
provide a relative comparison of detergent treatments that are consistent in finding with visual 
observations of the fiber network from SHG and SEM images.  
 
Figure 22: (A) Scanning electron microscopy of the detergent treated bladder fiber network. An (B-
C) automated algorithm was applied to quantify fiber network parameters of (D) fiber diameter, (E) pore 
size, and (F) node density [24]. C, T, and D represent the control, Triton™ X-100 pH 8, and sodium 
deoxycholate, respectively. Graph shows mean ± standard error, and * indicates significance at p<0.05. 
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Figure 23: 3-dimensional collagen fiber network rendering of the detergent treated bladder from 
SHG signal with TPM. Major tick represents 50 µm, whereby the total length and depth is 500 µm and 100 
µm, respectively. An integrated density function was applied and normalized to the control. Graph shows 
mean ± standard error, and * indicates significance at p<0.05. 
3.3.2 Heart Analysis 
3.3.2.1 dsDNA Content 
No visible nuclei were observed by imaging of Hematoxylin and Eosin stained sections (Figure 
24A). dsDNA quantification of the detergent treated hearts showed significant removal 
compared to the control (Figure 24B). Hearts treated with Triton™ X-100 with a pH 8 had the 
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largest amount of remnant dsDNA above 1000 ng/mg. Increasing the pH of Triton™ X-100 to 
11.4 more than halved the amount of remnant dsDNA. Hearts treated with sodium deoxycholate 
and SDS had the least amount of remnant dsDNA reduced to less than 100 ng/mg (209). Thus, 
the heart compared to the bladder required ionic detergents to achieve decellularization. This 
may be potentially due to unique differences in composition and structure such as the 
myocardium containing a higher tissue density and thickness than that of the bladder.  
 
Figure 24: Decellularization assessment of the detergent treated heart with (A) H&E to identify 
cellular content, and (B) Picogreen assay to quantify dsDNA. Scale bar represents 50 µm. Graph shows mean 
± standard error, and * indicates significance at p<0.05.  
3.3.2.2 Collagen and Sulfated GAG Content 
No decrease in soluble collagen was found for the detergent treated hearts (Figure 25). A 
decrease in soluble GAGs was found with treatment of all detergents except for Triton™ X-100 
pH 8. 
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Figure 25: Biochemical assay of the detergent treated heart to quantify soluble (A) protein, (B) 
collagen, and (C) GAGs. Graph shows mean ± standard error, and * indicates significance from control at 
p<0.05. 
3.3.2.3 Analysis of the Fiber Network 
SEM of the endocardial surface of the heart showed similar findings to that of the luminal 
surface of the bladder (Figure 26): Hearts treated with Triton™ X-100 pH 8, and sodium 
deoxycholate retained the original collagen fiber network compared to treatment with SDS. 
Surprisingly, increasing the pH of Triton™ X-100 to 11.4 resulted in an increase fiber diameter 
and decrease pore size possibly due to fiber fusion from denaturation (Figure 27). A multiple 
step protocol was also found to retain the original collagen fiber network.  
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Figure 26: Scanning electron microscopy of the detergent treated heart fiber network. 
 
Figure 27: automated algorithm was applied to Figure 26 to quantify fiber network parameters of 
(A) fiber diameter, (B) pore size, and (C) node density [24]. Graph shows mean ± standard error, and * 
indicates significance at p<0.05. 
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TPM imaging confirmed a loss of a distinct fiber network for hearts treated with SDS 
compared to Triton™ X-100 (Figure 28). The elastin fiber network was completely lost for 
treatment with either SDS or Triton™ X-100 at a pH of 11.4 (Figure 29).  
 
Figure 28: 3-dimensional collagen fiber network rendering of the detergent treated heart from SHG 
signal with TPM. Major tick represents 50 µm, whereby the total length and depth is 500 µm and 100 µm, 
respectively. An integrated density function was applied and normalized to the control. Graph shows mean ± 
standard error. 
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Figure 29: 3-dimensional elastin fiber network rendering of the detergent treated heart from 
autofluorescence. Major tick represents 50 µm, whereby the total length and depth is 500 µm and 100 µm, 
respectively. 
3.3.2.4 Mechanical Evaluation 
The passive failure force and stiffness of detergent treated heart tissue was found to be similar to 
that of the control (Figure 30). Thickness was found to decrease significantly after treatment as 
the muscle was removed during the decellularization process. 
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Figure 30: Ball burst test of detergent treated heart tissue with (A) failure force, (B) stiffness, and (C) 
the associated initial thickness. Graph shows mean ± standard error, and * indicates significance from control 
at p<0.05.  
3.1 DISCUSSION 
Thorough decellularization of tissues and organs is essential for promoting a constructive 
remodeling host response when such decellularized structures are used as therapeutic 
bioscaffolds for cardiac repair. However, exposure to certain decellularization agents can 
markedly disrupt the ECM. While some disruption of the ECM is inevitable, efforts should be 
made to minimize these detrimental effects. Four detergents commonly used for decellularization 
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of tissues and organs were systematically evaluated and compared for their effect on the 
composition, structure, and mechanics of two clinically relevant source tissues for cardiac repair.  
The detergents investigated were Triton™ X-100, sodium deoxycholate, CHAPS, and 
SDS. The detergents (88) were selected because of their frequent use as decellularization agents 
and their different chemical characteristics. Triton™ X-100 is non-ionic and disrupts lipid–lipid 
and lipid–protein interactions, while leaving protein–protein interactions intact. In contrast, 
sodium deoxycholate and SDS are anionic detergents which can solubilize cytoplasmic and 
nuclear membranes, denature ECM proteins, and disrupt native tissue structure. CHAPS is 
zwitterionic and exhibits properties of both non-ionic and anionic detergents. Therefore, it is not 
surprising that these detergents each have distinctly different effects on the ECM. Results of this 
aim show that these detergents may change the ultrastructure and composition of the ECM. 
While Triton™ X-100 most effectively retains the composition and structure of the ECM, it is 
less effective at removing dsDNA from dense and thick tissues such as the heart. Similarly, 
while SDS is effective at removing dsDNA, it is clear that it substantially damages the 
composition and structure of the ECM. Sodium deoxycholate was able to effectively remove 
dsDNA and retain the structure of the ECM. Surprisingly, while some detergents damaged the 
structure of the heart, the passive failure strength was unaffected. The passive failure strength is 
only one mechanical parameter measured at failure, and therefore does not necessarily imply that 
the mechanics of the heart are unaffected by detergent treatment.  
This aim provides the first comprehensive investigation of detergents for both tissue and 
whole organ decellularization examining the relationship of composition, structure and 
mechanics. These findings provide a template to formulate novel decellularization protocols 
depending on the complexity of the tissue of interest. For example, a thin cornea may possibly be 
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decellularized with a non-harsh detergent such as Triton™ X-100 to remove cellular material, but 
a dense thick tissue such as dermis may require a multiple step protocol. Indeed, in this aim a 
multiple step protocol that serially applies Triton™ X-100 and then sodium deoxycholate (190) 
was applied to the heart and successfully decellularized the tissue while retaining its structure.  
The choice of detergent used for the decellularization of a tissue or organ is an important 
factor in the preparation of an ECM scaffold for therapeutic applications. Each detergent, 
depending on its chemical characteristics, has unique and distinct effects on ECM composition 
and structure. Less disruptive non-ionic detergents, such as Triton™ X-100, will maintain the 
native structure and composition compared to harsher detergents, such as SDS, which denature 
essential ligands and proteins within the ECM. The disruption or denaturing of the native ECM 
architecture may negatively impact the interaction of the host cells with the ECM scaffold. The 
results of this study can aid in the formulation of tissue and organ decellularization protocols 
such that the innate biological activity of the resulting ECM scaffold is maximally preserved. 
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4.0  CYTOCOMPATIBILITY OF DETERGENT TREATED TISSUE3 
4.1 INTRODUCTION 
Specific Aim 2 identified damage to both the composition and structure of two relevant source 
tissues used to manufacture ECM scaffolds for cardiac repair after treatment with the detergents 
CHAPS and SDS. However, it is unknown whether these distinct structural differences may 
affect an ECM scaffold’s cytocompatibility. While a recent study found no difference in in-vitro 
cytocompatibility between three different rodent heart decellularization protocols, only a C2C12 
myoblast cell line was used to compare multiple step protocols (113). The observed 
compositional and structural changes in Specific Aim 2 may correspond with damage to specific 
domains of ECM constituents called ligands that are critical to cell-ECM interaction, and thus, 
warrant a more in depth cytocompatibility analysis.  
                                                 
3This work has been adapted from the following published manuscript:  
Faulk DM, Carruthers CA, Warner HJ, Kramer CR, Reing JE, Zhang L, D’Amore A, Badylak SF. The 
effect of detergents on the basement membrane complex of a biologic scaffold material. Acta Biomaterialia. 2013; 
Doi: 10.1016/j.actbio.2013.09.006. 
103 
A few previous examples of the composition and structure of an ECM scaffold 
influencing the host response should be recalled:  
1. Remnant cellular material (104, 105), or cross-linking an ECM scaffold is characterized by 
chronic inflammation and scar tissue formation. 
2. The method of terminal sterilization correlates with distinct differences in the host response 
(43).  
3. Site specific ECM scaffolds promoted significant improvement in differentiation and 
function in an in-vitro cell culture of a primary cell line (62, 63). 
Thus, the methodology of detergent treatment in Specific Aim 2 on two source tissues is 
repeated to investigate the relationship of an ECM scaffold’s composition and structure to 
cytocompatibility. It is hypothesized that the less harsh detergents which were shown in Specific 
Aim 2 to retain the structure and composition of ECM will have a higher level of 
cytocompatibility compared to the harsher detergents. 
4.2 METHODS 
4.2.1 Tissue Source 
The same two source tissues were used for their relevance in application to cardiac repair: 
Urinary bladder and heart. The tissue preparation protocol as described in Specific Aim 2 was 
followed. In brief, porcine urinary bladders were obtained from animals at a local abattoir 
(Thoma's Meat Market, Pittsburgh PA). Bladders were frozen (>16 hr at −80 °C) and thawed 
completely before use. The BMC and underlying lamina propria were mechanically isolated and 
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harvested from the bladders as previously described (102, 186, 194). The term detergent treated 
bladder refers to detergent treatment of the BMC and lamina propria of the bladder. Porcine 
hearts were obtained under controlled conditions to minimize damage to the vasculature near the 
surface (Tissue Source, Lafayette Indiana). Hearts were frozen (>16 hr at −80 °C) and thawed 
completely before use. For subsequent cell seeding after decellularization the right ventricular 
free wall was used because of its previous use as a cardiac patch (87). 
4.2.2 Decellularization Protocol 
The decellularization protocol as described in Specific Aim 2 was followed. In Brief, tissues 
were subjected to one of four commonly used detergents:  
1. A non-ionic detergent called Triton™ X-100 
2. A zwitterionic detergent called 3-[(3-cholamidopropyl)dimethylammonio]-1-
propanesulfonate (CHAPS) 
3. An ionic detergent called sodium deoxycholate 
4. An ionic detergent called sodium dodecyl sulfate (SDS) 
The concentration for decellularization of bladder and heart was chosen to both replicate 
those used in the literature while maintaining similar molarities (Table 6). CHAPS was only used 
for treatment of the bladder due to both cost constraints and its usage in the literature for only 
decellularization of a sheet such as the cornea. Table 7 from Specific Aim 2 describes in detail 
the decellularization protocol. Briefly, porcine bladders were treated with detergents by 
mechanical agitation while hearts were treated with detergents by whole organ retrograde 
perfusion. A multiple step protocol from the literature (71, 190) was also included to investigate 
serial detergent usage for heart decellularization because whole organs are more difficult to 
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decellularize. The goal of detergent treatment was not necessarily to reach the criteria for 
successful decellularization, but to compare the effect of detergent treatments on the source 
tissue under similar controlled conditions. Lastly, these detergent treated tissues were sterilized 
via gamma irradiation at a dose of 2 x 106 RADS.  
4.2.3 Cell Seeding and Culture 
The luminal surface of the sterilized detergent treated bladder and heart (i.e. endocardial) was 
placed facing up in a 6 well plate. The luminal surface was selected because of the presence of a 
BMC in the source tissue, an important structure for supporting endothelial cells (200). The 
regrowth of endothelium is critical to any cardiac repair strategy. Two cell lines were selected for 
their relevance to cardiac repair: An immortalized human microvascular endothelial cell line 
(HMEC-1) and a mouse myoblast cell line referred to as C2C12 cells. HMECs were chosen due 
to their relevance in assessing in-vitro whether endothelial cells can re-endothelialize on the 
surface of detergent treated tissues. C2C12 cells were chosen to assess if the detergent treated 
heart can support a muscle cell line. While it is understood that C2C12 cells differentiate into 
skeletal muscle instead of cardiac muscle this cell line was chosen as a first approximation of 
assessment.  
HMECs (a gift from Francisco Candal, Center for Disease Control and Prevention, 
Atlanta, GA) were cultivated in MCDB-131 medium containing 10% fetal bovine serum, 2 mM 
L-glutamine, 100 U/mL penicillin and 100 µg/mL streptomycin. MCDB-131 medium was from 
Invitrogen (Carlsbad, CA); all other reagents for cell growth were from Thermo Fisher Hyclone 
(Logan, Utah). HMEC cells were grown at 37°C in 5% CO2 and were harvested for seeding 
when they were approximately 100% confluent. C2C12 cells were cultured in Dulbecco’s 
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Modified Eagle Medium (DMEM) (Invitrogen) supplemented with 10% fetal bovine serum 
(FBS, Hyclone) and 100 U/ml penicillin/100 mg/ml streptomycin (Invitrogen). C2C12 cells were 
grown at 37°C in 5% CO2 and were harvested for seeding when they were approximately 70% 
confluent. 
HMECs and C2C12 cells were seeded on the luminal surface of each treatment group in 
triplicate. A total of 1 x 106 cells were cultured on each detergent treated tissue within a 2 cm 
diameter stainless steel culture ring containing 5 ml of culture medium. Detergent treated tissues 
were then placed in an incubator at 37°C in 5% CO2 for 24 hrs of culture, at which time the 
culture rings were removed and the seeded samples were transferred to a new 6 well plate with 
fresh media. Culture media was then replaced on day 2 and day 5. After 7 days of culture, seeded 
samples were fixed in 10% neutral buffered formalin, or gluteraldehyde for subsequent analysis. 
4.2.4 Scanning Electron Microscopy 
SEM was used to examine the surface topology of bladders treated with each detergent. SEM 
was also taken of the HMEC seeded detergent treated tissues after 7 days of culture on each 
sample. Samples were fixed in 2.5% glutaraldehyde in 1X PBS, cut into blocks of approximately 
8 mm3, and washed thoroughly in 1X PBS for three times at 15 minutes each. Samples were then 
fixed in 1% OsO4 in 1X PBS for 15 minutes each, and dehydrated in graded series of alcohol 
(30%-100%) baths for 15 minutes each. Samples were then critically point dried with 
Hexamethyldisiloxane mounted on studs, sputter coated, and stored in a desiccator until imaged. 
SEM images were captured enface using a JEOL 6335F Field Emission SEM with backscatter 
detector.  
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4.2.5 Semi-Quantitative Cell Scoring 
After 7 days of culture samples were fixed in formalin for at least 24 hours, embedded in paraffin 
and cut into 5 µm transverse sections. Detergent treated bladder tissue seeded with HMEC, and 
detergent treated cardiac tissue seeded with HMEC and C212 cells were sectioned and stained 
with Hematoxylin and Eosin (H&E). Images were taken of the HMEC – luminal interface. The 
images were then evaluated by five blinded investigators using a standardized system (106). 
Criteria included cellular infiltration, confluence, and cell phenotype. All aspects were evaluated 
on a scale of 0 to 100 percent described in Table 8 and Figure 31.  
Table 8: Description of semi-quantitative scoring of HMECs and C2C12 cells following seeding on 
the luminal surface of detergent treated urinary bladder and heart. 
Confluence (%) 
 
 
 
The confluence score is defined as the percentage of the surface covered 
with cells. A score of 100 would indicate a fully coated surface with 
adjoining cells and no gaps. 
 
Phenotype (%) 
 
 
 
 
 
The phenotype score is defined as the percentage of healthy appearing 
cells. A healthy cell is fully adhered to surrounding tissue and other cells. An 
unhealthy cell is round and not adhered to the surrounding tissue or other 
cells. Healthy HMECs cells become flat while C2C12 cells are more spindle 
shaped like a fibroblast.  
 
Infiltration (%) 
 
 
The infiltration score is defined as the percentage of the total depth in 
which cells have migrated within the tissue. For example, if cells are found 
halfway into the tissue, this would correspond to an infiltration score of 50. 
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Figure 31: Example images with associated semi-quantitative score for the metrics of (A) confluence, 
(B) phenotype, (C) and infiltration. 
4.2.6 Immunolabeling of Seeded HMECs on Detergent Treated Bladder 
Detergent treated bladder tissue sections were immunolabeled with integrin β1 because the 
luminal surface of intact bladders contain a BMC, and integrin β1 is critical to endothelial cell 
adhesion, migration, and survival (211). Slides for immunolabeling were deparaffinized and 
rehydrated with decreasing concentration of alcohol and water. Antigen retrieval was performed 
with Citrate Antigen Retrieval Buffer (10mM, pH6). Retrieval buffer was heated until a boiling 
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point was reached, slides were immersed, removed from heat, and cooled for 20 min. Slides were 
washed with 1X PBS 3x for 3 min each. 0.05% Pepsin digest was applied to samples for 15 min 
minutes in humidity chamber at 37°C. Blocking solution was applied (2% Goat serum, 1% BSA, 
0.1% Triton™ X-100, 0.1% Tween) for 1hr at room temp. Slides were washed with 1X PBS as 
above. Rabbit anti-integrin β1 (Abcam, AB52971, 1:1000) in blocking buffer was applied to 
each sample. The samples were then incubated at 4°C overnight. Slides were washed with 1X 
PBS as above. Alexa-Flour 594 goat anti rabbit (invitrogen, 1:200) was applied for 1 hr at room 
temperature. Slides were washed with 1X PBS as above. Coverslips were added with anti-FADE 
containing DAPI (Invitrogen, P36931). 
4.2.7 Statistical Analysis 
A one-way ANOVA was completed for each data set where the independent variable was 
detergent treatment with significance at p<0.05. if significance was found, either a post-hoc 
Dunnett’s test or Tukey’s test was completed to determine the specific differences between 
detergent treatment groups with significance at p<0.05. Graph shows mean ± standard error 
unless otherwise specified. 
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4.3 RESULTS 
4.3.1 Urinary Bladder Analysis 
4.3.1.1 SEM of Seeded HMECs  
Enface SEM of HMECs cultured on bladders treated with Triton™ X-100 (refer to methods for 
definition of bladder treated term) showed similar morphology and cell coverage to that of the 
control. SEM images of seeded bladders treated with sodium deoxycholate showed areas of 
HMEC coverage as well as exposed ECM. CHAPS and SDS, however, showed greater area of 
exposed ECM and less HMEC coverage than Triton™ X-100 and sodium deoyxcholate (Figure 
32). 
 
Figure 32: SEM images of HMECs cultured for 7 days on the luminal surface of detergent treated 
bladder tissue. 
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4.3.1.2 Semi-Quantitative HMEC Scoring 
HMECs cultured on detergent treated bladders that were treated with Triton™ X-100 had a 
similar level of confluence, a lower infiltration depth, and a similar phenotype compared to cells 
cultured on the control characterized by a flat morphology (Figure 33). HMECs cultured on the 
bladders treated with CHAPS were less confluent, had a greater infiltration depth, and an 
atypical phenotype compared to HMECs cultured on the control. HMECs cultured on bladders 
treated with sodium deoxycholate were less confluent, had a similar infiltration depth, and an 
atypical phenotype compared to cells cultured on the control. HMECs cultured on bladders 
treated with SDS had a similar percentage of confluence, had a similar infiltration depth, but had 
a less normal phenotype compared to cell cultured on the control. 
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Figure 33: (A) Representative H&E images of HMECs cultured on the luminal surface of detergent 
treated bladder tissue for 7 days. These images were semi-quantitatively analyzed by five blinded scorers for 
the level of HMEC (B) confluence, (C) infiltration, and (D) phenotype. Scale bar represents 50 µm. Graph 
shows mean ± standard error, and * indicates significance at p<0.05. 
4.3.1.3 Integrin β1 Expression 
HMECs cultured on the bladders treated with CHAPS and SDS had a lower number of cells 
stained positive for integrin β1 compared to HMECs cultured on the control. HMECs cultured on 
the bladder treated with Triton™ X-100 and sodium deoxycholate had a similar percentage of 
cells expressing integrin β1 compared to cells cultured on the control (Figure 34). 
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Figure 34: (A) Immunofluorescent images of integrin β1 (red) and DAPI (blue) of HMECs cultured 
on detergent treated bladder tissue for 7 days. (B) Percentage of cells positive for integrin β1 was determined 
for each group. Scale bar represents 50 µm. Graph shows mean ± standard error, and * indicates significance 
at p<0.05.  
4.3.2 Heart Analysis 
4.3.2.1 Seeded HMEC Evaluation 
SEM of HMECs cultured on detergent treated hearts had a similar response to that seen in 
detergent treated bladder (Figure 35). Confirmation through scoring of HE stains (Figure 36 & 
Figure 37) found that hearts treated with Triton™ X-100 at pH 8 had a confluent layer while 
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increasing the pH to 11.4 resulted in some areas of exposed ECM. Hearts treated with sodium 
deoxycholate showed areas of HMEC coverage as well as areas of exposed ECM, and hearts 
treated with SDS and a multiple step protocol showed large amounts of exposed areas of ECM. 
While both hearts treated with SDS and a multiple step protocol had large areas of exposed ECM 
by transverse H&E, examination with enface SEM revealed patches of confluence for hearts 
treated with the multiple step protocol but not for SDS.  
 
Figure 35: Enface SEM images of HMECs cultured for 7 days on detergent treated heart tissue.  
115 
 
Figure 36: Representative transverse H&E images of HMECs cultured on detergent treated heart 
tissue for 7 days. Scale bar represents 50 µm.  
 
 
Figure 37: H&E images of detergent treated heart tissue reseeded with HMECs for 7 days were semi-
quantitative analyzed by five blinded scorers for HMEC (A) confluence, (B) infiltration, and (C) phenotype. 
Graph shows mean ± standard error, and * indicates significance at p<0.05. 
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4.3.2.2 Seeded C2C12 Evaluation 
C2C12 culture on detergent treated heart tissue found confluent cell layers on all surfaces from 
enface SEM (Figure 38), transverse H&E (Figure 39), and scoring of tranverse H&E images 
(Figure 40). Hearts treated with SDS treatment also had a higher level of cellular infiltration 
compared to treatment with Triton™ X-100 and sodium deoxycholate indicating disruption of the 
luminal surface. From enface SEM, the morphology of C2C12 cells was also irregular for hearts 
treated with SDS.  
 
Figure 38: SEM images of C2C12 cultured for 7 days on detergent treated heart tissue. 
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Figure 39: Representative H&E images of C2C12 cultured on detergent treated heart tissue. Scale 
bar represents 50 µm. 
 
Figure 40: H&E images of detergent treated heart tissue reseeded with C2C12 for 7 days were semi-
quantitative analyzed by five blinded scorers for C2C12 (A) confluence, (B) infiltration, and (C) phenotype. 
Graph shows mean ± standard error, and * indicates significance at p<0.05. 
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4.4 DISCUSSION 
A strong relationship that was dependent on the cell type was found to exist between the 
detergent treatment and cytocompatibility for two source tissues relevant to cardiac repair. 
Specifically, Triton™ X-100 treatment had a high level of in-vitro HMEC-1 cytocompatibility 
followed by sodium deoxycholate, whereas CHAPS and SDS treatment had poor 
cytocompatibility. A multistep protocol combining treatment with Triton™ X-100 and sodium 
deoxycholate also had a moderate level of in-vitro HMEC-1 cytocompatibility. C2C12 cells were 
found to be less sensitive to the differences between detergent treated samples. These findings 
correlated well with the findings from Specific Aim 2 that indicated that the composition and 
structure of the ECM were best retained through treatment with Triton™ X-100 and sodium 
deoxycholate, whereas treatment with CHAPS and SDS damaged the fiber network and triggered 
a loss of ECM constituents. While only two immortalized cell lines were investigated, this 
finding of a complex  relationship between the type of cell and ECM is well known.  
The relationship between the cells and ECM is related to cell integrin-ECM ligand 
interaction. Cellular integrins form adhesions to ECM constituents such as collagen, fibronectin, 
and laminin through specific ECM domains known as ligands which contain recognizable 
sequence motifs such as RGD (212, 213). Cellular integrins are heterodimeric transmembrane 
glycoprotein receptors with a head domain connected to either adjacent cells or these ECM 
ligands and a cytoplasmic tail domain that is bound to the cytoskeleton-signaling network. 
Integrins are defined by their non-covalently associated α and β subunits, with most integrins 
binding to more than one ECM protein, and most ligands recognized by more than one integrin.  
This aim examined the β1 subunit for its relevance to the HMEC-1 cell line. β1 integrin 
was not present when CHAPS or SDS was used. This lack of β1 integrin for CHAPS and SDS 
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detergent treatment correlated with the damaged composition and structure of the ECM, and the 
poor cytocompatibility of the ECM. This lack of β1 integrin may be due to the cell’s inability to 
recognize important ECM ligands resulting from damage to the ECM as seen from other criteria 
in Specific Aim 2. This concept is further supported by the previous finding that investigated the 
surface of ECM scaffolds which were either prepared from different source tissues or cross-
linked, and analyzed by the techniques of SEM and time of flight secondary ion mass 
spectroscopy. These techniques found differences between the different treatment groups with 
respect to their ligand landscapes (194). 
The finding of a lack of cell-ECM interaction for harsher detergents clearly results in a 
decreased number of cells remaining on the ECM, but also may affect signal transduction from 
the ECM to the cell. At these cell-ECM interfaces a focal adhesion complex exists where the 
integrin is coupled to the internal actin cytoskeleton and cytoplasmic proteins such as paxillin. 
These cytoplasmic proteins regulate different kinase families such as focal adhesion kinase. 
These kinase families mediate downstream signaling processing events to regulate cell functions 
such as migration, proliferation, differentiation, and protein synthesis.  
This complex signaling cascade may be activated by a tissue level mechanical stimulus. 
Specific Aim 1 clearly identified a complex relationship between the ECM fiber network and the 
cell. This mechanical relationship extends from the size scale of the tissue and cell level down to 
subcellular mechanisms. Cell integrins act as cellular mechanosensors whereby a local 
mechanical force may cause a confirmation change in the integrin. This conformation change can 
activate a focal adhesion kinase. The focal adhesion kinase initiates downstream signaling 
pathways that affect cellular physiology (214, 215). Thus, this cell integrin – ECM ligand 
interaction is critical to a healthy cell’s function. For example, if an integrin that is associated 
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with binding to collagen is blocked the cell alignment will actually be lost (151). 
Cardiomyocytes whose integrin were blocked actually lost proper myofibrillar patterning and 
alignment (216). This mechanical relationship between the cell and the ECM fiber network, 
otherwise known as mechanobiology, serves to emphasize the importance of understanding how 
damage to the ECM scaffold composition and structure as seen in in Specific Aim 2 affects the 
cell-ECM interaction. 
Thus, the findings of Specific Aim 2 and Specific Aim 3 coupled with information on cell 
integrin – ligand ECM interaction indicate that the composition and structure of an ECM scaffold 
are critical to cellular function and are closely associated with detergent treatment. The detergent 
comparisons herein provide a comprehensive database of each detergent to make an educated 
decision on the balance between decellularization and the retention of the composition, structure, 
and cytocompatibility of the ECM scaffold. Retention of these variables may prove critical to 
cellular physiology, and in turn tissue homeostasis and remodeling.  
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5.0  DISSERTATION SYNOPSIS  
5.1 MAJOR FINDINGS 
The present work compared the effect of different detergent treatments for tissue and whole 
organ decellularization on an ECM scaffold’s composition, structure, mechanics, and 
cytocompatibility. This is the first time the three classes of detergents have been 
comprehensively compared under similar treatment conditions. The major findings for this work 
are as follows: 
  
Specific Aim 1: To acquire a quantitative understanding of ECM micromechanics. 
• An interrelationship exists between ECM composition, ECM structure, cellular gene 
expression, and cellular deformation as a function of mechanical loading that is highly 
specific to the anatomic location.  
o At the tissue level, the AV was thicker and had a stiffer mechanical response than the 
PV under biaxial load possibly due to its inherently higher transvalvular pressure.  
o At the cell level, the PV valvular interstitial cells underwent substantially larger 
deformations than the AV valvular interstitial cells. These cellular deformations 
correlated with collagen fiber kinematics and were layer dependent.  
o At the gene level, the AV had a higher level of expression of ECM constituents than 
the PV. 
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• Layer dependent cellular-collagen micromechanical coupling exists. 
o At the tissue level, the MV has two opposing fiber networks. 
o At the cell level, valvular interstitial cell deformation was greatest in the layer with 
the highest density of collagen fibers. 
  
Specific Aim 2: To determine if the structure and mechanics of ECM scaffolds are altered as a 
function of different detergent treatments. 
• Treatment with the zwitterionic detergent CHAPS and the ionic detergent SDS damaged the 
composition (loss of GAG and elastin) and structure (collagen fiber denaturation) of the 
source tissue, whereas treatment with the non-ionic detergent Triton™ X-100 and ionic 
detergent sodium deoxycholate were able to retain this complex composition and structure. 
However, increasing the pH of Triton™ X-100 from 7.4 to 11 resulted in partial damage to 
the composition and structure. For the heart, failure strength was unaffected by detergent 
treatment. 
• Treatment with sodium deoxycholate and SDS were effective at removing dsDNA through 
both tissue mechanical agitation and whole organ perfusion, while treatment with Triton™ X-
100 was only able to effectively decellularize thin tissues through mechanical agitation. 
Increasing the pH of Triton™ X-100 resulted in an increased removal of dsDNA but was still 
not sufficient to decellularize an entire organ. 
• A multiple step protocol with Triton™ X-100 and sodium deoxycholate was able to 
effectively decellularize an entire organ while retaining its composition and structure. 
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Specific Aim 3: To determine if cell-ECM interaction is dependent upon the detergent treatment. 
• Treatment with Triton™ X-100 resulted in a high level of HMEC-1 in-vitro cytocompatibility 
followed by sodium deoxycholate, whereas treatment with CHAPS and SDS resulted in a 
poor level of cytocompatibility. Increasing the pH of Triton™ X-100 from 8 to 11 resulted in 
decreased HMEC-1 cytocompatibility. C2C12 in-vitro cytocompatibility was insensitive to 
detergent treatment. 
• Treatment with a multiple step protocol combining Triton™ X-100 and sodium deoxycholate 
also resulted in a high level of HMEC-1 in-vitro cytocompatibility.  
• These detergent dependent cytocompatibility findings correlated with the compositional and 
structural findings from Specific Aim 2 indicating that a complex relationship exists between 
the cell and the ECM.  
5.2 OVERALL CONCLUSIONS 
This body of work found that the composition, structure, and cytocompatibility of an ECM 
scaffold are dependent on the type of detergent selected to achieve decellularization. While this 
work focused on two source tissues for cardiac repair, the information herein may be 
extrapolated to different decellularization applications. From these findings, a profile of each 
detergent was created to assist in the formulation of an optimized decellularization protocol 
depending on the source tissue of interest.  
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Table 9: Detergent profile for decellularization. Green, yellow, and red indicate positive, neutral, and 
negative, respectively. 
 
Cost Decellularize Composition Structure Mechanics Cytocompatibility 
Triton™ X-100 
pH 8             
Triton™ X-100 
pH 11.4             
CHAPS 
             
Sodium 
Deoxycholate             
SDS 
             
Multiple Step 
Detergent             
 
 
For example, based on the findings represented in Table 9 a thin cornea could be 
decellularized with a non-harsh detergent such as Triton™ X-100 to remove cellular material. 
However, a dense and thick tissue such as dermis may require a multiple step protocol. From this 
Table it may be postulated that the tissue should first be treated with a non-harsh detergent such 
as Triton™ X-100 to remove the majority of cellular material, followed by sodium deoxycholate 
to remove the remainder. Indeed, in this work a multiple step protocol that serially applies 
Triton™ X-100 and then sodium deoxycholate (190) was applied to the heart and successfully 
decellularized the tissue while retaining its composition, structure, and cytocompatibility. If the 
tissue is still not sufficiently decellularized it may require the application of SDS; however, with 
the information in Table 9 an investigator should recognize the importance of minimizing the 
application of such a harsh detergent.  
At present, this is not the case. Many investigators utilize SDS for prolonged periods of 
time ranging from 12 to 120 hours (Table 4, and Table 5). Surprisingly, multiple step protocols 
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that do not contain SDS are reported to decellularize whole organs in as little as 10 hours with 
the application of an ionic detergent, sodium deoxycholate, for only three of the hours of 
treatment (71, 190). Thus, application of many of the protocols reported in Table 4 and Table 5 
may have been formulated with the objective only to achieve decellularization due to the 
prolonged period of treatment with powerful detergents. The work of this dissertation elucidates 
the need to balance between achieving decellularization and retaining composition, structure, and 
cytocompatibility. This information will assist both academic laboratories and industry in further 
optimization of decellularization protocols to create ECM scaffolds with the highest levels of 
compositional and structural integrity along with excellent cytocompatibility.  
5.3 FUTURE WORK 
The work presented herein contributes to the foundation of knowledge that may optimize the 
manufacturing of ECM scaffolds. While other components of the manufacturing process such as 
source tissue (62, 63), remnant cellular material (104, 105), cross-linking (104), and method of 
terminal sterilization (43) have been found to impact the host remodeling response it is not clear 
whether different detergent treatments may have a similar effect. Clearly, from Specific Aim 1 
there is an anatomically complex micromechanical relationship between cells and the collagen 
fiber network of ECM. Damage to this collagen fiber network as seen with harsh detergents in 
Specific Aim 2 may affect the mechanobiology of the implanted ECM scaffold, subsequently 
altering the host outcome. Thus, the finding of this body of work that detergents may alter 
composition, structure, and cytocompatibility of the ECM scaffold indicates that there is a strong 
possibility that there will be an inherently different host responses as a function of different 
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detergent treatments. Further in-vivo studies are warranted to identify the level of correlation of 
host tissue response to detergent treatment. If clear differences exist, an in-vitro mechanistic 
study should investigate how detergent treatment impacts site-specific tissue repair with primary 
cell harvests and site-appropriate mechanical loading from protocols developed in Specific Aim 
1. This knowledge will lead to the optimization of site-specific ECM scaffold design for the 
reconstruction of complex tissues and organs. 
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